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ABSTRACT 
 
 
Graphene is an atomically thin carbon nanomaterial, with a honeycomb structure. 
It has generated enormous scientific interest since its discovery in 2004. 
Graphene has a set of unique properties, which has made it a highly suitable 
material for the potential use in electronic devices, photonics and bioapplications, 
including the use in a new generation of biosensors, over the past few years. 
Graphene has already demonstrated high sensitivity to various biological 
molecules which come into contact with its surface. However, there have been 
virtually no studies of the mechanisms of the interactions between graphene and 
biological materials, particularly the cell membrane, the biological component 
which will be in direct contact with graphene. Understanding these interactions is 
central to the use of graphene-based materials in drug delivery systems and its 
biological safety and is also relevant to the development of many types of 
biosensors.   
 The work presented in this thesis provides an insight into the 
fundamental interactions between graphene oxide (GO), and graphene-based 
materials, with the cell membrane. By using model membrane systems, the aim 
is to reveal how GO interacts with cell membranes, the extent to which it affects 
the structure of the membrane, with the potential to further research the biological 
processes that occur at the membrane. Studies on Langmuir monolayers, using 
lipid mixtures representative of the composition of the inner and outer leaflets of 
a typical cell membrane, found that the nature of GO interaction with biological 
membranes may be dependent on the lipid composition, with results suggesting 
significant repulsive forces between GO and negatively charged phospholipids. 
The second model membrane system investigated were lipid bilayer vesicles. 
Two preparations of vesicles were used, one containing only neutral 
phosphatidylcholine lipids and the other containing two types of neutral lipid, as 
well as cholesterol and a stabilising molecule. GO was shown to permeate both 
vesicles without causing complete lysis. This suggests GO interacts specifically 
with at least one type of neutral lipid molecule within the vesicle bilayer. This is 
further supported through an investigation into GO interactions with a real cell 
membrane. In red blood cells (RBC’s) the interaction of GO increases membrane 
		6	
stiffness, but does not cause haemolysis, suggesting that it does not penetrate 
the biological membrane.  This suggests GO is interacting with the outer lipid of 
the membrane, but it is possible the negatively charged lipids in the inner leaflet 
of the membrane prevent the GO from entering the cell. The increase in 
membrane stiffness suggests GO is interacting with the lipids altering the 
properties of the membrane.   
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OVERVIEW OF THESIS 
 
 
Chapter 1 introduces graphene, explaining the important properties relevant to 
understand its biological applications, the different sources of graphene and 
allotropes of carbon. The biological cell membrane structure and properties will 
be described. Previous literature investigating the interactions of graphene with 
biological cells is presented, including the different effects of graphene reported, 
with an introduction to graphene biosensors, identifying where there are gaps in 
the previous research. There are three main experiments [Chapters 2 – 4] 
conducted in this thesis which were chosen to provide complementary results in 
this research.  
 Chapter 2 describes studies on the interaction of graphene with lipid 
monolayers, providing structural information about how graphene oxide interacts 
with mixed-lipid monolayers, mimicking the lipid composition of the inner and 
outer leaflet of the cell membrane. The aims are to determine the mechanisms of 
the cell interactions using a Langmuir trough, and also to prepare Langmuir 
Blodgett films for biosensor applications.  
Chapter 3 investigates the permeability of graphene oxide with model 
bilayer membranes, using two preparations of bilayer vesicles. Optical density 
measurements and fluorescence techniques are used to measure permeability 
changes to the bilayer.  
Chapter 4 extends this study to a real cell membrane, that of the red blood 
cell. In addition to fluctuation spectroscopy, haemoglobin absorbance is 
investigated, as well as using Raman spectroscopy to determine the location of 
graphene oxide within the cell.  
 Chapter 5 concludes the work and includes suggestions for future 
experiments that can resolve some of the inconclusive results within our work 
such as GO biocompatibility.  
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Chapter 1 Background 
	
	
1.1 Properties of Graphene 
	
	
Graphene is one atom thick, planar sp2-bonded carbon honeycomb 
crystal. Each carbon atom is bound to three neighbouring carbons, with a bond 
length of 1.42 Å, and all bond angles at 120° (1) (2) [Figure 1.1]. Graphene has 
two structural regions: the basal plane, and the edge. Edges form from breaks in 
the graphene structure, leaving a one-atom thick line of carbon atoms with 
dangling bonds that can be utilised for functionalisation of graphene.   
	
	
	
Figure 1.1	Polyaromatic honeycomb structure of graphene 
	
Graphene, known theoretically since 1947, was first isolated in 2004 by Andre 
Geim and Konstantin Novoselov (3), for which they won the Nobel Prize in 
Physics in 2010. Since then, graphene has generated a lot of attention due to its 
many interesting and exciting properties, reviewed by Geim and Novoselov (4), 
and its use in applications in many different fields such as: condensed matter and 
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high–energy Physics (5) (6) (7), material science (8) (9), electronics (10) and 
many bioapplications including biosensing (11) (12).  
Its unusual properties make it a unique material to consider when looking 
at potential applications in the biomedical field. It is chemically inert so cannot be  
destroyed by solvents or acids. It is electrically conductive so can be used as a 
sensing surface either as an electrode for electrochemical sensing, or as the 
conductive channel of a field-effect transistor. It also exhibits high optical 
transparency. 
The mechanical properties of graphene are important when considering 
its potential to be integrated into flexible sensing platforms and when interacting 
with biological cells. The mechanical properties of monolayer graphene have 
been measured, finding the strength to be 130 GPa and a high Young’s modulus 
of 1.0 ± 0.1 TPa (13). This compares to chemically modified graphene (obtained 
by reducing GO using a hydrogen plasma) which has been reported to have a 
Young’s modulus of 0.25 ± 0.15 TPa (14). The Young’s modulus, otherwise 
known as the elastic modulus, measures the resistance of a material to elastic 
deformation. The high Young’s modulus calculated for graphene is indicative of 
a flexible material. However, mechanical properties can be influenced by surface 
defects such as overlapped grain boundaries, pinhole and microcracks, with 
several papers reporting the behaviour of graphene with such defects (15) (16). 
One simple defect of graphene is caused by missing carbon atoms within the 
honeycomb lattice. If many carbon atoms are missing the graphene could 
become energetically unstable. If an odd number of atoms are missing dangling 
bonds will be present within the graphene structure, leaving the graphene more 
unstable and reactive. The strong reactivity can weaken the mechanical stability 
of the graphene (15). As well as high flexibility, graphene also has a large surface 
to volume ratio, the importance of which will be explained in Section 1.5.1.  
The wettability of the surface of graphene is important in determining its 
biocompatibility. Graphene is reported to be hydrophobic (17) determined by 
wetting graphene films and measuring the contact angle of the droplet [Figure 
1.2] 
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Figure 1.2 Water droplet on the surface of graphene. The contact angle q is used to 
determine the wettability. 
described by Young’s equation,  
 
 𝛾"# = 𝛾"% + 𝛾%# cos 𝜃  
  (1.1) 
where q is the contact angle, gsl is the solid/liquid interfacial free energy, gsv is the 
solid surface free energy and glv is the liquid surface free energy. These terms 
collectively represent the surface tension between the liquid and solid surface 
measuring the hydrophobic forces (18). The contact angle of water on graphene 
has been calculated to be approximately 100°, making graphene more 
hydrophobic than graphite, which has a contact angle of ~ 90° (17). Factors that 
can affect the water contact angle include physical roughness of the surface or 
topology, contaminants on the surface, and chemical functionalisation. Because 
of the structure of graphene, it is possible to manipulate its wettability through 
functionalisation of the surface for specific applications. For example, Schneider 
et al. assembled a pyrene ethylene glycol monolayer on the surface of graphene, 
forming a hydrophilic surface, preventing DNA from adsorbing to the graphene 
through π-π interactions, allowing graphene nanopores to detect single-stranded 
DNA using the ion current passing through the pore (19). The wettability is an 
important property when considering the biocompatibility of graphene. Due to its 
hydrophobicity, it proves difficult to obtain stable aqueous dispersions of 
graphene, and this could potentially limit its use in biological applications. In this 
thesis, graphene oxide [Section 1.2.3], will be investigated due to its hydrophilic 
nature. 
Another interesting property of graphene is the ability to tailor the chemical 
reactivity of the surface. The electronic structure of graphene is the basis of its 
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chemical properties. Manipulating the surface chemistry for a specific application 
is of great importance since the chemical composition impacts the electronic 
structure, as well as the chemical reactivity. As previously mentioned, graphene 
is chemically inert. This is due to its giant stabilised delocalised π bonding 
system, where 6 unpaired π-electrons are shared between the 6 carbon atoms 
of the ring creating regions of electron density above and below the plane of the 
ring.  
 
Shown below are the remaining p orbitals (the other orbitals involved in sp2 
hybridisation), one on each carbon atom, which overlap to generate 6 molecular 
orbitals.  
 
This structure allows for functionalisation of graphene through π-π interactions 
which occurs with other aromatic molecules above or below the benzene plane, 
where p orbitals can also overlap, generating an attractive force. Other π-
interactions can occur such as metal-π interactions where there is a non-covalent 
interaction with the region of electron densities, and polar-π interactions. 
Although, defects within the graphene plane can alter the electronic structure, 
changing the chemical properties. One common reaction that alters graphene 
properties is the oxidation of graphene to graphene oxide, which will be described 
in the next section.  
Graphene can be prepared through several different methods. The 
different methods can be broadly categorised into sections described below. For 
further detail on graphene preparation see the review paper “A Roadmap for 
Graphene” (20).  
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1.2 Preparation of Graphene 
	
	
1.2.1 Exfoliated and CVD Graphene 
	
Geim and Novoselov (3) initially used the mechanical exfoliation technique 
in order to obtain single layer graphene. This is achieved by peeling layers of 
graphene away from a block of graphite using scotch tape. It is more likely that 
thin graphite stacks are pulled away from the bulk graphite, so it requires multiple 
exfoliation steps to achieve single layer graphene. The single layer graphene on 
the tape can then be transferred to a solid substrate, where optical microscopy is 
required to identify the single layers, by locating the flakes and measuring the 
optical contrast between the flake and the substrate. This method can produce 
single-layer graphene as well as a range of multi-layers. Further analysis of the 
graphene flakes via atomic force microscopy (AFM), for example, can be used to 
measure the thickness of the flakes through height profiles of the samples. This 
process gives samples with the best electronic and optical properties, however, 
the size of the flakes produced are not suitable for large scale applications.  
The next method for preparing graphene samples involves the growth of 
graphene via chemical vapour deposition (CVD) on a metal substrate such as 
nickel or copper, from carbon-containing gases. It can be used to form mono- or 
multilayer graphene sheets. For many applications, CVD graphene must be 
transferred to an insulating substrate. However, this transfer process can cause 
structural defects, impurities and tearing, which affect the physical properties of 
graphene. This method has already been shown to produce graphene on a 
meter-scale (21), but is of a poorer quality compared to exfoliated graphene. It 
can also be expensive to produce CVD graphene on this larger scale due to a 
large consumption in energy (20).  
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1.2.2 Graphene Oxide and Reduced Graphene Oxide 
	
Graphene is naturally hydrophobic, meaning it is non-dispersible in water. 
However, when oxidised it forms graphene oxide (GO) which is hydrophilic and 
easily dispersible in water [Figure 1.3].  
 
 
 
Figure 1.3 SEM image of graphene oxide flakes. 1 mg/ml graphene oxide was dispersed 
in water and sonicated for 1h, then centrifuged at 10,000 rpm for 10 min.  
Due to the polar oxygen-containing groups on the GO surface (hydroxyl, 
epoxy and carboxyl functional groups), hydrogen bond formation can take place 
between the GO and water, forming stable GO suspensions. GO is usually 
prepared using a method based on the proposed method by Hummers and 
Offeman, which produces GO through the treatment of graphite flakes with 
potassium permanganate, sodium nitrate and sulfuric acid, at temperatures 
below 45°C (22). Oxidation of graphene breaks the network of conjugated bonds, 
and delocalised π-electrons. This renders GO insulating as the conductivity of 
graphene relies on its continuous sp2 carbon network. GO sheets are also 
atomically rough due to this functionalisation. Mkhoyan et al. also found that the 
degree of oxidation fluctuates at the nanometre-scale (23).  
GO has been described as a random distribution of oxidised areas with 
oxygen-containing functional groups, combined with non-oxidised regions where 
most of carbon atoms preserve sp2 hybridisation (24). However, the precise 
structure of GO is still unclear, with several proposed structural models (25) (26) 
(27). The widely accepted model is that of Lerf and Klinowski (26) (27), with the 
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hydroxyl, epoxy, and carboxyl groups covering the GO plane and edges. The 
reactive functional groups of graphene oxide make it a good candidate for use in 
many applications through chemical functionalisation.  
Graphene oxide sheets can be reduced to graphene, known as reduced 
graphene oxide (rGO). A variety of chemical methods can be used to reduce 
graphene oxide, the most common uses hydrazine monohydrate (24). Reducing 
graphene oxide with strong reducing agents, such as lithium aluminium hydride, 
is challenging due to possible side-reactions with the solvents graphene oxide is 
dispersed in. The reduction of GO aims to remove all oxygen-containing groups 
and other defects, as well as restoring the p-bond network to recover some of the 
important graphene properties, including its electrical conductivity. Different 
reduction processes will restore the graphene structure and properties to different 
extents, affecting the final properties of the rGO, usually only resulting in partial 
reduction. This method leaves the graphene with structural defects; however, this 
could be advantageous for electrochemical applications as it has been shown 
that the electrochemistry of graphene occurs at the edges, or at defects in the 
basal plane (28). 
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1.3 Allotropes of Carbon 
	
	
Two other allotropes of carbon have been used in this thesis, highly oriented 
pyrolytic graphite (HOPG) and diamond [Figure 1.4].  
 
	
	
Figure 1.4 Image showing substrates of Highly Oriented Pyrolytic Graphite, HOPG (left), 
and Boron-Doped Diamond, BDD (deposited on a silicon substrate) (right). 
 
Graphite consists of layers of graphene held together by weak van der Waal’s 
forces, allowing the layers to slide over one another and thereby making graphite 
a soft material. In contrast, diamond consists of a tetrahedral network of 
covalently-bonded sp3 carbon atoms and is one of the hardest natural materials 
[Figure 1.5].  
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Figure 1.5 The carbon structure of graphite (left) and diamond (right). The graphite is 
formed from atomically thin sp2 graphene layers held together by van der Waal’s forces, 
indicated by the dotted lines.  Diamond is a covalent tetrahedral structure of sp3 carbon 
atoms. 
Natural graphite exhibits a lot of defects. HOPG is a highly pure and 
ordered form of graphite. It is synthesised using a technique called pyrolysis, by 
heat treatment of pyrolytic carbon. It is characterised by a mosaic spread angle, 
describing the alignment of the graphite crystals. A low mosaic spread is 
indicative of a well aligned sample. When synthesising HOPG, additional tensile 
stress is applied in the basal plane to improve alignment of the crystals. Because 
of its layered structure, HOPG can be cleaved by pressing tape onto the surface 
then pulling it off taking a thin layer of HOPG leaving a clean surface that is 
atomically smooth and highly stable. HOPG is a conductive material, with its 
conductivity determined by the quality of the HOPG surface. With an increase in 
defects on the surface, a decrease in conductivity is observed (29), showing the 
need for a planar surface. Like graphene, HOPG is also reported to be 
hydrophobic. Kozbial et al. found a contact angle of 64.4 ± 2.9°. Hydrophobicity 
is said to increase due to contamination from hydrocarbons adsorbing to the 
surface (30). Graphene films have also shown the ability to tailor its surface to 
achieve superhydrophobicity (contact angle ~ 160°) by sonicating in acetone, and 
superhydophilicity (contact angle ~ 10°) by sonicating in water (31).  
The electrochemical properties of HOPG have been of great interest, 
particularly when looking at similarities and differences between the 
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electrochemistry of HOPG and graphene, as they share the same basic carbon 
structure. HOPG is also a frequently used source for exfoliated graphene. Further 
knowledge of the electrochemical properties of HOPG will give an understanding 
of a variety of processes such as carbon surface functionalisation (32) and 
electrocatalysis (33). The basal plane of HOPG has already been used as an 
electrode support for various applications (34) (35), including biosensing [Section 
1.5.2], but there have been conflicting reports on the electrochemistry of the basal 
surface. Until recently, it was generally thought that the basal plane had very low 
activity (36), with the step edges present across the HOPG surface providing all 
the electron transfer sites. A thorough study of the electrochemical properties of 
HOPG was conducted by Patel et al. using different grades of HOPG and varying 
in step-edge height and coverage. They found the same electrochemical 
behaviour on all substrates and fast electron transfer on the pristine basal plane 
(37).  
For this thesis, the diamond used is doped with boron. The properties of 
boron-doped diamond (BDD) are determined by the chemical quality of the 
surface, the level of boron-doping and its physical structure. Diamond itself is 
insulating, but when doped with boron will become conductive. Boron is the most 
widely used dopant, due to its low charge carrier activation energy of 0.37 eV 
(38). Boron films are usually prepared via chemical vapour deposition or the high 
pressure, high temperature (HPHT) process, where some of the carbon atoms in 
the diamond structure are substituted with boron, which gives the diamond 
electrical conductivity. Boron is introduced to the diamond through boron-
containing substances such as diborane or trimethylborane. Low doping levels 
gives the diamond p-type semi-conductor properties (39) (40) whereas at high 
levels it acts as a semi-metal. This differs from other dopants such as phosphorus 
or nitrogen which produce n-type semiconductors. The general observation from 
previous work is that the conductivity of BDD is strongly dependent on the doping 
level. An increase in crystal imperfections has also been observed from boron-
doping (41). High quality BDD has also shown excellent electrochemical 
properties, which allows it to be used as an electrode in a range of applications 
(42) (43). Its role in biosensors is described in Section 1.5.2.  
The next section introduces the biological cell, describing in detail the 
structure and properties of the cell membrane. It includes details of all 
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components of the cell membrane: lipid composition and different classes of lipids 
and the membrane proteins and cytoskeleton. The mechanical properties of the 
cell membrane will also be explained. A review of the previous research 
investigating the interaction of graphene with biological cells is also given.  
 
	
1.4 The Biological Cell 
	
	
Biological cells, discovered by Robert Hooke in 1665, form the basic 
functional and structural unit of all biological organisms [Figure 1.6].  
 
 
 
Figure 1.6 Diagram of a 2-dimensional eukaryotic cell, showing the different organelles 
present within a typical cell.  
The adaptation of cells has led to many types of cells with different functional 
roles working in many different environments. The most important cellular 
structure for the work of this thesis is the cell membrane, which is relatively similar 
in structure in all cells.  
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1.4.1 The Cell Membrane 
	
The cell plasma membrane, forming its external surface, is one of the main 
components of all biological cells. Organelles in eukaryotic cells are also bound 
by membranes of similar structure. Many of the cell’s important activities occur at 
the cell membrane, or involve highly specific transport processes through it. The 
cell membrane acts as a mechanical and chemical barrier between the inside of 
the cell, and its surroundings. It controls what can pass into the cell, and prevents 
the diffusion of other molecules. The other functions of the cell membrane 
include: the sorting and transportation of molecules; recognition; transmission 
and transduction of signals; and expression of genetic identity. There is great 
diversity in molecular composition and organisation of biological membranes, 
specific to these different functions.   
	
	
1.4.2 The Structure of Biological Cell Membranes 
	
A typical cell membrane consists of a lipid bilayer stabilised by 
hydrophobic interactions, which may be coupled on its inner surface to a protein 
network known as the cytoskeleton. Within the lipid bilayer, there are various 
types of proteins embedded, with a range of functions, some of which are 
anchored to the cytoskeleton providing mechanical support for the cell [Figure 
1.7].   
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Figure 1.7 A typical biological membrane structure. The membrane is formed of a 
phospholipid bilayer, also containing other lipid molecules such as cholesterol. Examples 
of the different phospholipid structures are given in Figure 1.8. There are also various 
proteins serving different structural and physiological functions. Some of the integrated 
proteins act as attachment points for the cytoskeleton protein network. 
	
	
1.4.3 The Phospholipid Bilayer 
	
Cell membranes have complex lipid compositions varying between cells, 
depending on their purpose. The phospholipids are the most abundant lipid in 
most cell membranes. They are amphiphilic molecules, consisting of a hydrophilic 
head group, and hydrophobic fatty acid chains [Figure 1.8].  
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Figure 1.8 a) Basic structure of a phospholipid. R1 and R2 represent fatty acids, normally 
containing 12-20 carbons and one or more unsaturated bonds. X represents a more 
hydrophilic group such as a choline forming the head group b) The full structures of the 
primary phospholipids used in this thesis (from Avanti Polar Lipids, Inc. (44)).  
Phospholipid bilayers spontaneously form due to the hydrophobic 
interactions of the lipid tails, forming a barrier between the inside of the cell, and 
the outside. They arrange so that the hydrophilic head groups are on the inside 
and outside of the cell, with a hydrophobic region in between, minimising the 
interactions between the hydrophobic tails and the surrounding water molecules. 
Phospholipids consist of a phosphate head group, containing either a glycerol or 
sphingosine base, and two fatty acid chains. Phospholipids are characterised by 
their head group and, also, by the number, length and degree of saturation of the 
fatty acid chains. The primary head groups include choline, serine, glycerol, 
ethanolamine, inositol and phosphatic acid. For example, a commonly used 
phospholipid 16:0 PC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine or DPPC) 
has a choline head group, attached to two identical 16-carbon saturated fatty acid 
chains [Figure 1.8]. The size of the lipid head group and the degree of saturation 
of the fatty acid chains will affect their packing within the membrane and influence 
the curvature of the membrane. 
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Lipid systems can form a variety of two-dimensional phases, from gaseous 
to solid. They can undergo temperature-dependent phase transitions and the 
temperature at which these occur is specific to each lipid species. The 
phospholipid bilayer is generally described as a 2-dimensional liquid. This is 
because the lipids are free to move around on the 2-dimensional surface of the 
membrane. However, this picture is complicated by the proteins associated with 
the membrane and by formation of lipid domains (45) and lipid rafts (46) within 
the membrane.  
In 1972, Singer and Nicholson proposed the fluid-mosaic model 
demonstrating the membrane structure, giving evidence of the organisation of 
lipids and proteins within the membrane based on thermodynamic analysis of the 
hydrophobic interactions.  The molecules organise into a structure that gives the 
lowest free energy (47) [Figure 1.9]. 
 
 
Figure 1.9 The Fluid Mosaic Model as proposed by Singer and Nicholson showing the 
phospholipid bilayer with embedded membrane proteins (from (47)). 
The cell membrane is asymmetrical (48) (49) (50) with different lipids 
distributed in the two halves of the bilayer. The asymmetrical distribution of lipids  
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is fundamental to many cellular processes. The two different monolayers are 
known as the inner and outer leaflet of the membrane. For example, the 
membrane of human erythrocytes contains almost all the sphingomyelin [Section 
1.4.5] and PC in its outer leaflet. Lipids with neutral or negatively charged head 
groups are found in the inner leaflet. The membrane actively maintains this lipid 
asymmetry, as well as the asymmetry between proteins and other structures.  
 
	
1.4.4 Other Membrane Lipids 
	
Although the phospholipids are the most abundant lipid in the cell 
membrane, there are other lipids that contribute to the membrane. Cholesterol is 
a lipid molecule also found in cell membranes, differing in percentage between 
membranes (~ 30-50 mol%). It is defined as amphipathic, containing a hydrophilic 
region and a lipophilic region. Due to the structure of cholesterol [Figure 1.10], it 
is classed as a sterol, with the network of hydrocarbon rings being a signature to 
all steroid hormones and a short hydrocarbon chain that easily intercalates into 
the lipid bilayer. It is a vital component of cell membranes and is also used by cell 
to synthesise other steroids.  
	
	
 
Figure 1.10 The molecular structure of Cholesterol, one of the membrane lipids (from 
Avanti Polar Lipids, Inc. (44)). 
Cholesterol decreases the permeability of the membrane by increasing the 
hydrophobicity of the barrier to polar molecules and also helps strengthen the 
bilayer. It is also important for the formation of domains within biological 
membranes. Cholesterol intercalates between acyl chains of phospho- and glyco-
lipids in the membrane, resulting in a decrease in area per molecule that may 
promote phase separation within the bilayer, favouring interactions with saturated 
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chains. Cholesterol is able to move rapidly between the different leaflets of the 
membrane, due to a lower free-energy barrier compared to phospholipids (51). 
Cholesterol will also favour interactions with sphingolipids, another lipid molecule 
found in the cell membrane, which tend to have longer, more saturated 
hydrocarbon chains. According to the “Umbrella Model” the preferential mixing of 
cholesterol with sphingolipids is due to shielding of non-polar cholesterol, from 
the polar sphingolipid head groups (52) (53), as opposed to intermolecular 
interactions. These interactions further contribute to domain formation.  
Sphingolipids are a class of lipids with an amino-alcohol backbone, a polar 
head group and two non-polar tails. Their basic structure has allowed for vast 
modification producing a class of lipids with diverse structure and function [Figure 
1.11].  
 
 
 
Figure 1.11 The structure of the predominant species, sphingosine, present in all 
sphingolipids (from Avanti Polar Lipids, Inc. (44)). 
Sphingolipids located in the cell membrane play important roles in the 
structure of the membrane, in signal transmission and cell recognition, as well as 
serving as adhesion sites for extracellular proteins.  
 
 
1.4.5 Lipid Bilayer Mechanics 
	
The mechanical properties of a cell membrane influence the structure and 
function of the cell. Characterising these mechanical properties provides an 
insight into the physiological state of the membrane, important for studying the 
effects of disease or administration of drugs, for example. In the context of this 
thesis, they are likely to influence the interaction of the membrane with graphene. 
The mechanical properties of a thin membrane are described as one of three 
types of deformation: in-plane extension at a constant area (shear), bending or 
curvature change, and area expansion (stretching) (54) [Figure 1.12].  
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Figure 1.12 The deformations of a 2-D membrane: shear, bending and area expansion. 
There are two widely used models used to investigate membrane elasticity. They 
are giant vesicles and the red blood cell (RBC), which consists of a representative 
cell membrane encapsulating a haemoglobin solution. Giant vesicles have a low 
bending modulus and a shear modulus close to zero, whereas the RBC 
membrane is supported by the cytoskeleton, increasing both moduli, producing a 
more rigid membrane. A detailed explanation of this will be given in Chapter 4.  
 
 
1.4.6 Lipid Monolayers 
	
Much of our understanding of the physical properties of membranes has 
emerged from studies on lipid monolayers. They form readily at air-liquid and 
liquid-liquid interfaces due to the amphiphilic nature of the molecules, which self-
organise in one phase or another. Work on these monolayers relevant to this 
project is reviewed in Chapter 2. Because the phospholipid bilayer of the cell 
membrane can be considered as two weakly interacting monolayers, the phase 
behaviour of lipid monolayers can be loosely used to describe that of lipid 
bilayers. However, other factors within the bilayer can also contribute to changes 
in phase and must be considered. These considerations include: stresses 
induced by membrane curvature, as well as curvature driven phase separation 
and curvature induced by changes in lipid composition, and lipid ‘flip-flop’, where 
lipids can move from one leaflet of the bilayer to another.  
		
	
		
	
	
	
		
Shear Deformation Bending Area Expansion 
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 Although there are difficulties in accurately comparing the properties of 
monolayers and bilayers, the monolayer is an important tool in research. 
Monolayer systems can be used to measure various phase transitions of pure 
phospholipids and more complex lipid systems, further described in Chapter 2. In 
biological membranes these transitions are important to understand, since the 
properties of a membrane can change dramatically.  
	
	
1.4.7 Membrane Proteins and the Cytoskeleton 
	
Within the cell membrane there are various types of proteins, with various 
different functions, that also contain hydrophobic and hydrophilic regions, like the 
phospholipids. This allows for proteins to interact with the membrane, whether 
they are able to sit inside the membrane or attach to the outside of the membrane, 
with parts anchored into the cell. Integral (trans-membrane) proteins have 
hydrophobic domains which span the phospholipid bilayer, whereas peripheral 
(membrane-associated) proteins have smaller domains which intercalate in only 
one half of the bilayer [Figure 1.6]. These proteins are generally involved in cell-
cell signalling. Integral proteins may form domains within the membrane, some 
form channels or pores to assist in transporting molecules in and out of the cell, 
usually specific to the type of ion or solute. Other integral channel proteins use 
active transport to move molecules in and out of the cell against concentration 
gradients.  
The proteins that are most important to cell membrane mechanics are 
those that are attached to the cytoskeleton. The cytoskeleton is the network of 
proteins surrounding the cell, providing structural support, as well as having 
important roles in cell mitosis and meiosis, intracellular transport of cell organelles 
and the transduction of chemical and physical signals into the cell. 
 
 
1.4.8 Graphene Interacting with Biological Cells 
	
This main aim of the work in this thesis is to investigate the interactions 
between graphene and biological cells. Initial research has already been carried 
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out investigating the antibacterial properties of graphene (55) (56) (57). Akhavan 
and Ghaderi found bacterial cell membrane damage through direct contact of the 
sharp edges of graphene nanowalls and the bacteria, showing reduced graphene 
oxide to be more toxic than graphene oxide (55). Hu et al. (56) reported graphene 
and graphene oxide solutions effectively inhibit bacterial growth as well as severe 
membrane damage to E. coli cells, with GO exhibiting a slightly stronger 
antibacterial effect. It was suggested the cause of damage was due to oxidative 
stress, caused by a disturbance in the balance between the production of reactive 
oxygen species (ROS) and the cells antioxidant defences (58), or by physical 
damage. They also demonstrated cellular uptake of graphene oxide in a 
mammalian cell line, A549, a human lung carcinoma epithelial cell line, finding 
graphene oxide inside the endosome of the cytoplasm, suggesting internalisation 
via	endocytosis with minimal cytotoxicity (56). rGO exhibited significantly higher 
cytotoxicity. Krishnamoorthy et al. agree, generally, with previously reported 
mechanisms of toxicity. However, they also present results suggesting graphene 
specifically disrupts the outer membrane of the bacteria, leading to cell death 
(57). It is important to consider the interactions of these graphene-based 
materials with bacteria, however, as already shown by Hu et al., it is possible 
graphene will interact differently when in contact with mammalian cells, due to 
structural and functional differences.  
Reports of toxicity of graphene oxide towards mammalian cells have also 
been presented. Chang et al. investigated the toxicity of graphene oxide towards 
A549 cells finding graphene oxide did not enter the cells, nor exhibit cytotoxicity 
towards the cell. However, at high concentrations, graphene oxide only induces 
slight loss in cell viability, concluding graphene oxide to be a safe material at the 
cellular level (59). There has also been research conducted investigating the 
toxicity of graphene oxide towards human erythrocytes, the red blood cells. Liao 
et al. showed size and dose-dependent haemolytic activity of graphene oxide. 
Low haemolytic activity was observed with aggregated graphene sheets (60). By 
measuring the haemoglobin absorbance, the authors were able to determine the 
percentage of haemolysis in a cell population, and therefore the toxicity. 
However, little detail is given on how the graphene is interacting with the cell to 
cause cell lysis. The differences in observations of toxicity and interactions show 
the necessity to further investigate the mechanisms of interactions.  
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Another one of the aims of this research is to understand the interactions 
of graphene with biomolecules and cells that are relevant to its use in biosensors, 
which will be discussed in the next section.  
	
	
1.5 Biosensors 
	
	
Biosensors are used to detect a range of biologically active molecules, 
sensitively and selectively. They are of great importance in various fields such as 
security and environmental safety, as well as point-of-care analyses within health 
care, with a strong demand to produce highly selective and sensitive, cost-
effective sensors. Biosensors are devices that use a biological component to 
detect biological materials, and convert the information into an analytically useful 
signal. They are constructed from two elements: a receptor and a transducer. The 
receptor generally consists of a biological component, such as DNA or a protein, 
which has a specific interaction with another molecule. The receptor is the 
recognition element of a biosensor. A biological response is induced on 
recognition of the specific biomolecule. The transducer converts the information 
into a measurable signal, proportionate to the concentration of the biomolecule 
[Figure 1.13].   
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Figure 1.13 An example of a biosensor showing the biological recognition of a specific 
molecule which activates the receptor to produce a biological response, which is amplified 
and processed by the transducer to give a readable signal. 
	
	
1.5.1 Graphene Biosensors 
 
Carbon-based nanomaterials, especially graphene, have attracted a great 
research interest in the field of biosensing. There have been several review 
articles published on the use of graphene in biosensing (28) (11) (61). Described 
here are the important properties of graphene that contribute to its use as a 
sensing platform, as well as some examples of the different types of biosensor 
graphene has been used in. 
The properties of graphene make it an excellent material for the use in 
biosensing devices. Graphene flexibility is important for the development of 
biosensors that are portable, wearable and possibly implantable, such that the 
final biosensor could be applied to a curved surface, eg. a surface on the human 
body. For graphene to be used in various biosensing systems, the graphene 
surface may require functionalisation in order to immobilise particular 
biomolecules, for example, antibodies. Graphene can form covalent bonds, as 
well as π-π stacking interactions which binds any aromatically linked receptor 
molecules through non-covalent attractive forces between aromatic rings, which 
are all advantageous for surface functionalisation allowing a range of molecules  
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to attach to its surface. Graphene’s large surface to volume ratio allows for 
increased loading of the specific biomolecules to the surface to enhance the 
sensitivity of the biosensor. As graphene is also electrically conductive and 
optically transparent, it can be used as an electrochemical, conductive or optical 
transducer. The combination of these properties gives potential advantages for 
use of graphene in biosensors.  
Field-effect Transistors (FETs) are one type of biosensor that, constructed 
with graphene, has shown great potential. FETs measure the change in electric 
charge distribution at the receptor. In an FET, the charge carrier density in the 
graphene can be controlled by a voltage applied to the transistor gate. Molecules 
on the surface of the graphene exchange charge with it, with the gate allowing 
the charge exchange to be measured. Graphene-based FETs have been used in 
the detection of DNA molecules, due to the charged phosphate backbone of the 
DNA. Dong et al. showed the detection of DNA hybridisation, with single base 
specificity, by using CVD graphene transistors functionalised with probe-DNA to 
measure the charge transfer between the DNA and graphene (62).  
Electrochemical impedance has been used in biosensing platforms 
showing high sensitivity. Graphene, functionalised with hairpin-DNA via π-π 
stacking between the ring of the nucleobase and the graphene, has been used 
for the detection of DNA hybridisation (63), by measuring electrochemical 
changes when the DNA hybridises with the complementary target. 
Electrochemical biosensors are highly sensitive to electroactive molecules, and 
also highly selective in that different molecules can be oxidised or reduced at 
different potentials. Electrochemical reactions occur at the interface between the 
electrolyte solution and the electrode surface. With graphene, electron transfer 
can occur at the edges or at defects in the basal plane. Graphene’s large surface 
area can facilitate a large number of defect sites, increasing electroactive sites. 
Graphene has been utilised in many glucose-sensing mechanisms used for 
diagnoses of diseases such as diabetes. The enzyme glucose oxidase is used 
as the biorecognition element immobilised on the graphene surface. It oxidises 
glucose to gluconic acid and hydrogen peroxide, the latter can be directly 
measured providing useful for glucose detection (2). There have also been 
developments toward non-enzymatic graphene-glucose biosensors using 
metal/metal oxide based catalysts. The presence of glucose is determined by the 
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electrooxidation of glucose to glucolactone caused by the redox reaction of the 
metal (12). This method has been developed to eliminate several problems which 
arise when using enzymes (eg. glucose oxidase) including; pH; temperature; 
humidity and toxic chemicals which could denature the enzyme (64).  
Graphene has also been used in fluorescence biosensors due to its ability 
to quench fluorescence. It has been previously used in the detection of thrombin 
(65). In this work, graphene was functionalised with an aptamer labelled with a 
fluorescent dye. Fluorescence recovery was measured when the thrombin 
attached to the aptamer. As well as biomolecules, graphene has been used to 
detect whole single cells. Ang, et al. have developed a graphene transistor, 
functionalised with specific biorecognition proteins, integrated with a microfluidic 
channel, to allow a “flow-catch-release” sequence to detect malaria-infected red 
blood cells. A change in graphene conductivity indicates an infected cell has been 
“captured” (66).  
Although graphene biosensors have exhibited good sensitivity and 
selectivity, there are still many challenges to overcome in order to develop 
consistent and reproducible graphene sensors for large-scale manufacturing, 
critical for commercialisation. This next section describes two other carbon 
materials that have also been used as a sensing platform within biosensing 
devices. 
 
 
1.5.2 HOPG and BDD Biosensors 
	
In this thesis, HOPG has been used to provide a model for graphene 
biosensing, as it can be considered as multi-layer graphene. As described in 
section 1.3, HOPG has advantageous electrochemical properties that can be 
used in biosensor applications. Like graphene-based biosensors, it is important 
that specific biomolecules are immobilised on the HOPG surface in order for 
specific detection. Previously, HOPG, functionalised by p-stacking of pyrene-
based linker molecules attached to antibodies, has been used as a label-free 
electrochemical impedance biosensor to detect the sepsis marker procalcitonin 
by measuring the charge-transfer resistance between the redox probe, and the 
HOPG surface (67). HOPG has also been functionalised with pyrene for 
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immobilising DNA on its surface for use as an electrochemical DNA-sensor (68) 
(34).   
BDD has also been used in this thesis due its great potential as an 
electrochemical biosensor. BDD biosensors exhibit a low and stable background 
current which gives improved signal-to-background and signal-to-noise ratio, and 
a low limit of detection. It also has a wide working potential window. The diamond  
surface is chemically and mechanically stable resisting severe morphological 
changes. It also exhibits good electrochemical activity and a fast response time. 
BDD biosensors have been shown to be highly sensitive and specific, 
reproducible, as well as exhibiting long-term stability and good biocompatibility 
(69) (70). They have been used to detect a variety of biomolecules including 
important neurotransmitters (70).  
		
	
Chapter 2 Langmuir Monolayer Studies and Langmuir-
Blodgett Deposition 
 
 
In this chapter, I will be discussing experiments carried out looking at the 
interactions of Langmuir monolayers formed from membrane phospholipids and 
solutions of graphene oxide. I will also be describing the experimental formation 
of lipid bilayers onto graphene and other carbon substrates, using both the vesicle 
fusion method and Langmuir-Blodgett deposition.  
The aim of this experiment is first to clarify the mechanisms of interaction 
between phospholipids and GO to inform later studies on the interactions of GO 
with cells. A further aim is to establish whether bilayers can be formed on model 
carbon substrates. Firstly, to determine the arangement of phospholipids on a 
solid carbon surface and, secondly, whether the bilayers have sufficient integrity 
for potential use in electrochemical detectors. 
 
 
2.1 Introduction 
	
	
2.1.1 Langmuir Monolayers 
	
Langmuir monolayers are widely used for studying the chemical and physical 
surface properties of insoluble monolayers of amphiphilic molecules at the air-
water interface. Primarily, they are used to obtain pressure-area isotherms for 
lipid monolayers to measure the phase behaviour and dynamics of different lipid 
systems. They also allow the possibility to generate and control lateral surface 
pressure in order to appropriately model biological membranes with a surface 
pressure of ~ 30 - 35 mN/m.  
Monolayers have been extensively used to study the physical properties 
of the individual lipids of the plasma membrane and interactions between them, 
providing a powerful tool to examine the behaviour and roles of lipids in biological 
cell membranes. It is important to consider the structural arrangement of the lipid  
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molecules within the membrane, to understand the different roles of the lipids. 
There is a great interest, in particular, in investigating the phospholipid systems 
found in biological membranes. Different lipid compositions will have a preferred 
molecular packing arrangement, serving specific roles in the function of the 
membrane such as the mechanical properties, two-dimensional phase behaviour, 
or the formation of lipid domains and rafts. Evidence suggests the lipids in most 
biological membranes are in a fluid phase (71), a property vital to many cell 
processes.  
There have been many studies characterising phase behaviour of pure 
and mixed lipid monolayers using pressure-area isotherms (72) (73), as well as 
utilising other techniques such as fluorescence microscopy, Brewster angle 
microscopy (BAM), grazing incidence x-ray diffraction (GIXD) and dipole potential 
measurements which can be used, for example, to monitor domain formation 
(74). It is important to note that analysis of mixed lipid monolayers can be 
complicated due to the presence of lipid domains in equilibrium or non-equilibrium 
metastable domains. Using microscopy techniques together with the construction 
of pressure-area isotherms, it is possible to work with lipids extracted from a 
specific cell membrane, and compare the domain formation of well-characterised 
pure lipid systems with the complex lipid system of the cell membrane to identify 
the role of specific lipids in domain formation.   
Langmuir monolayers have also been extensively used as a model 
membrane system to investigate biological reactions in two-dimensions, the 
effects of proteins and other biomolecules on molecular organisation, 
viscoelasticity and electrostatic interactions. The first such attempt extracted 
lipids from erythrocyte ghost cell membranes (cell-like structure consisting of only 
a membrane), and compared the area of the monolayer to the surface of the 
ghost cells. This found the monolayer area to be half of the area measured for 
the ghost cell membrane, suggesting that the cell membrane consists of two 
monolayers (75). Another excellent example utilising the Langmuir model system 
was a study of the lipid composition of lung surfactant (76). Lung surfactant is a 
naturally occurring monolayer with a complex mixture of lipids and proteins, which 
forms at the air-alveolus interface. The most abundant lipid being DPPC, which 
is widely agreed as the lipid responsible for the near-zero surface tension at the 
alveolar surface at the end of exhalation. This is an essential property of the lung 
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surfactant which increases surface pressure as the alveolar area decreases, thus 
preventing lung collapse (76). The Langmuir monolayer is able to mimic some of 
the properties of lung surfactant, such as the ability to lower surface tension, and 
the re-spreading of lipids during inhalation, aided by a surfactant protein.  
Langmuir monolayers have also been used to study the interactions of lipid 
monolayers with molecules such as proteins added to the subphase below. 
Importantly, they have been used to investigate interactions of lipids with 
anticancer drugs for the optimisation of drug delivery (77), as well as the 
interactions of proteins with brain lipid extracts when investigating 
neurodegenerative diseases (78).  
Another method for studying lipid-protein interactions incorporates the 
protein with the lipids before monolayer formation. This has been used to 
understand the aggregation of peptides characteristic of Alzheimer’s disease, 
within a lipid membrane. The peptides investigated include amyloid beta proteins 
(and amyloid forming proteins) which are produced in the lipid membrane causing 
neuronal death (79). Adsorption of these peptides into a Langmuir monolayer 
were studied to determine the nature of the interaction to investigate the 
mechanism and origin of Alzheimer’s disease. They measured surface pressure 
and surface potential – area isotherms to give information on the interactions 
between the lipids and peptides. An increase in surface pressure was observed 
on adsorption of the peptides/proteins indicating attractive forces between the 
two molecules. Combining this study with other spectroscopic techniques can 
further characterise the structure of the monolayer and determine the orientation 
of the lipids of the monolayer to give a greater insight to the mechanisms in which 
the peptides act within the membrane (80).  
In addition to studying lipid monolayers, other amphiphilic molecules that 
form a monolayer at the air-water interface can be studied. Previous research, 
for example, has utilised the Langmuir monolayer technique to analyse the 
surface chemistry properties and structural behaviour of particular enzymes (81) 
and hormones including insulin using the same characterisation techniques used 
to study lipid monolayers (82).  
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2.1.2 Langmuir Trough Construction 
	
The Langmuir trough is shown schematically in Figure 2.1. The trough and 
barriers are made of a hydrophobic material such as Teflon. The trough is filled 
with a fluid subphase to produce a meniscus bounded by the trough and the 
barriers. The barriers are controlled mechanically to allow for accurate 
adjustment of the trough area.  
 
 
 
Figure 2.1 The Langmuir Trough. The two moveable barriers are used to adjust the surface 
area of the trough, and compress and relax the lipid monolayer spread on the liquid 
subphase. The sensor probe measures the 2-dimensional surface pressure. The magnetic 
flea and stirrer are used to evenly distribute solutes added to the subphase. 
	
A lipid monolayer is spread over the surface of the subphase between the two 
barriers, to allow for compression and relaxation of the monolayer. This directly 
controls the surface concentration (area/molecule). The changes in molecular 
packing of the lipids during compression are observed by a change in surface 
pressure (π) Surface pressure is defined as the difference between the surface 
tension of the pure subphase, and the surface tension of the Langmuir film:  
 
 𝜋 = 	𝛾- − 𝛾(𝑐) 
 
 
(2.1) 
where γ0 is the surface tension of pure water (72.8 mN/m at 20°C), and γ is the 
surface tension of the film-covered surface, as a function of concentration (c).  
Surface tension is measured as the downward force on a probe in contact with, 
but not immersed in, the air-water interface. To eliminate uncertainties arising 
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from the contact angle of the meniscus at the probe, the probe has to be 
completely wetted by the surface of the film i.e. a contact angle of zero. The 
surface pressure and trough area are plotted against each other to produce a 
pressure-area isotherm.  
 
	
2.1.3 Surface Pressure – Area Isotherms 
	
The lipid phase behaviour of the films is usually characterised by the construction 
of pressure-area isotherms, in which the area/molecule (Å2) is changed 
sufficiently slowly to achieve equilibrium at each pressure. The lipid monolayer 
can exist in different phases and undergo phase transitions. The isotherm shows 
distinct phase regions with their characteristic gradients. Phase coexistence 
appears as a plateau in the isotherm, an ideal first order transition [Figure 2.2].  
	
	
	
Figure 2.2 A generalised π-A isotherm of a Langmuir monolayer, showing the molecular 
arrangement of lipids at the distinct phase regions during compression. From (83).  
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The lipids can exist in phases ranging from gaseous to solid with increasing 
pressure. At low pressures, the monolayer is said to be in the gaseous phase. 
Molecules on the surface are widely spread and disordered. Compression of the 
film triggers a phase transition to the liquid-expanded phase where molecules 
remain disordered and fluid. Further compression induces another phase 
transition to the liquid-condensed state, also known as the tilted-condensed state. 
At higher pressures, the monolayer can reach the untilted-condensed phase (the 
solid phase). Molecules in the final phases are ordered, with the molecules in the 
solid phase almost perpendicular to the surface, as opposed to the tilted 
orientation of the molecules in the liquid-condensed phase. When in the solid 
phase, further compression can lead to the monolayer collapsing. Molecules are 
forced out of the monolayer at these high surface pressures and form disordered 
multilayers on the surface. Changes in the gradient (incremental elastic modulus) 
in the isotherm indicates a change in phase which are determined by 
intermolecular interactions including van der Waal’s forces between hydrocarbon 
chains and attractive or repulsive electrostatic or steric interactions between head 
groups. 
The dilational modulus, Î, also known as the surface elasticity modulus 
(84), can be used with the p-A isotherm to give a better understanding of the 
mechanical properties of the lipid monolayer:  
 
 𝜖	 = 	 𝑑𝛾𝑑 ln𝐴 = 	 −𝑑𝜋𝑑𝐴 𝐴   
(2.2) 
It describes the change in surface tension, 𝛾, produced by the corresponding 
change in surface area, A, of the monolayer. A plot of the dilational modulus vs 
surface pressure can provide further information on the subtle features in the 
phase behaviour as well as details on the rigidity of the monolayer upon 
compression (85).  
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2.1.4 Studying the Interaction of Graphene and Lipids 
	
There has been only a single application of the Langmuir monolayer to the study 
of graphene interactions with lipids. Shanghao Li, et al. investigated interactions 
between graphene oxide and five lipids with different head groups carrying 
different charges (Dioctadecyldimethylammonium bromide (DODAB), 1,2-
Distearoyl-sn-glycero-3-ethylphosphocholine chloride salt (DSEPC), 1,2-
distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-distearoyl-sn-glycero-3-
phosphate sodium salt (DSPA) and stearic acid). They found that graphene oxide 
can be incorporated into positively charged monolayers, but not neutral or 
negatively charged monolayers. This led them to conclude that the cellular uptake 
of graphene oxide is due to biological processes such as endocytosis, rather than 
phospholipid interaction, due to a lack of positively charged lipids present in 
biological membranes (86). However, the cell membrane contains a complex 
mixture of lipids [Chapter 1] and this conclusion seems premature. An aim of the 
present work is, therefore, to investigate the interactions of graphene with lipid 
mixtures representative of those in the inner and outer leaflets of the plasma 
membrane of a typical cell.  
	
	
2.1.5 Supported – Lipid Bilayers 
	
Supported-lipid bilayers are another commonly used system to model the cell 
membrane. Depositing model membranes onto solid substrates allows studies of 
biological processes that occur at the cellular level, as well as the potential to be 
used in biosensor applications.  Described here are two of the methods proposed 
to deposit the membranes: the vesicle fusion method and Langmuir-Blodgett (LB) 
deposition.  
In the vesicle fusion method, lipid bilayer vesicles are allowed to adsorb to 
a solid support when they spontaneously rupture, forming a bilayer on the 
surface. This method has been used by Tzusuki et al (87). They investigated 
formation of DOPC lipid membranes to determine a structural model in which lipid 
mono- and bilayers arrange on a reduced graphene oxide support. Their results 
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suggest that an initial monolayer is deposited onto rGO, but loosely arranged with 
a tilted orientation [Figure 2.3].  
 
 
	
Figure 2.3 Tzusuki et al. proposed arrangement of lipid layers on reduced graphene oxide 
supported on SiO2/Si. Substrates were incubated with vesicle suspensions, 
spontaneously forming lipid layers. From (87). 
The limitations of this approach, particularly important in the development of 
biosensors, are that surface coverage of the substrate is generally incomplete 
and that the lipid packing density cannot be controlled. This technique has also 
been used to deposit lipid layers onto graphene for sensing applications (88), 
which will be discussed in Section 2.1.6.  
Langmuir-Blodgett deposition overcomes the limitations of the vesicle 
fusion method. The apparatus [Figure 2.4] allows the substrate to be drawn 
through a Langmuir monolayer transferring part of the monolayer to the substrate. 
By setting the initial surface pressure and using a feedback system to keep it 
constant (by altering the barrier separation during the substrate movement), the 
lateral packing of the monolayer can be controlled. The orientation of the initial 
lipid monolayer is controlled by the hydrophobicity of the substrate. Hydrophilic 
substrates must be immersed in the subphase, before the lipid monolayer has 
been added, enabling a lipid monolayer to be deposited as the substrate is raised 
through the surface. Hydrophobic substrates are held above the subphase, then 
lowered through the monolayer, to allow lipid deposition. By repeated dipping, 
multilayers can be formed [Figure 2.5].		
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Figure 2.4 The Langmuir trough set up for Langmuir-Blodgett deposition. A controlled 
dipping mechanism is used to control the movement of the substrate through the lipid 
monolayer on the trough surface. 
	
	
Figure 2.5 Diagram showing different lipid deposition on different surfaces. First, a 
hydrophilic surface raising through the lipid monolayer. Second, the same hydrophilic 
surface lowered through the monolayer, depositing a second layer on the surface. Third, 
a hydrophobic surface lowered through the lipid layer to deposit a monolayer. 
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2.1.6 Electrochemical Biosensors 
	
Electrochemistry is a sensitive and inexpensive technique used to selectively 
detect electroactive analytes. Graphene is an attractive substrate for these 
sensors offering the prospect of combining electrochemical detection with 
another modality such as optical sensing. Graphene can also be produced with 
a low environmental impact and at a low cost. Because many biomolecules target 
the cell membrane, the concept for this sensor is to form a membrane mono- or 
bilayer mimicking a cell membrane on the graphene surface to detect the 
interaction of the target molecule through measuring changes in electron transfer, 
for example. Electron transfer between a solution species and an electrode can 
be affected by several factors: the properties of the solution species, its rate of 
diffusion through the electrolyte solution, and the presence of adsorbed species. 
In this case a phospholipid mono/bilayer can restrict electron contact with the 
surface of electrode, blocking electron transfer. It is this blocking effect that offers 
potential detection methods.  
 Ideal electrochemical detection requires a three-electrode system: a 
reference, a counter and a working electrode. The redox reaction being studied 
occurs at the working electrode. The reference electrode, usually Ag/AgCl, 
maintains a constant potential at the working electrode and the current flowing 
between the working electrode and a counter electrode is measured using a 
potentiostat [Figure 2.6].  
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Figure 2.6 Three-electrode electrochemical cell (right) and a simple redox reaction 
occurring at the working electrode (left). O is the oxidised species, R is the reduced 
species, e- is a single electron, ko is the oxidation reaction rate constant and kR the 
reduction reaction rate constant. 
Shown in Figure 2.6 is a simple scheme of the redox reaction that occurs 
at the working electrode:  
 
 𝑂 + 𝑛𝑒	:;:<	𝑅 
 
 
 
 
where O and R are the oxidised and reduced forms of the redox couple at the 
interface of the working electrode and n is the number of electrons exchanged 
between O and R. kR and kO are the reaction rate constants for the reduction and 
oxidation reactions.  
Potentiometric devices measure the potential at the sensor interface, 
determined by the Nernst equation which governs the relationship between 
analyte concentration and potential in these reactions: 
 𝐸?@%% 	= 	𝐸?@%%- −	𝑅𝑇𝑛𝐹 𝑙𝑛 [𝑅]F[𝑂]F 
 
 
 
(2.3) 
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where Ecell is the zero-current cell potential, 𝐸?@%%-  is the formal potential 
contribution to the cell, R is the universal gas constant, T is the temperature in 
degrees Kelvin, n is the charge number of the electrode reaction, F is the Faraday 
constant, and [R]/[O] is the ratio of ion concentration at the anode to ion 
concentration at the cathode.  
The electrochemical method used in this thesis is cyclic voltammetry. 
Cyclic voltammetry obtains information by applying a potential at the working 
electrode and then measuring the resulting current. The resulting current is then 
plotted against the applied potential [Figure 2.7].  
	
	
	
Figure 2.7 Cyclic voltammogram at a HOPG electrode in 0.1 M ruthenium hexamine at a 
scan rate of 50 mV/s, with an Ag/AgCl reference electrode and a Pt counter electrode. Ipc 
and Ipa are the cathodic and anodic current peaks. Epc and Epa are the cathodic and anodic 
peak positions and E1 and E2 are the potential limits of the voltammogram. 
Cyclic voltammetry gives information about the redox potential and 
electrochemical reaction rates of analyte solutions. By considering the current 
peak ratio, GHIGHJ, and the current peak potential separation, 	∆𝐸H = 𝐸H? − 𝐸HM, the 
reversibility of the redox reaction can be assessed. For rapid, reversible systems, 
the current peat ratio is equal to one, and the peak potential separation  ~ NO.QR  mV 
at 25°C, where n is the number of electrons transferred.  
There have been a number of measurements on phospholipid bilayers 
supported on substrates such as glassy carbon, silicon dioxide (SiO2) and gold 
(89), often with the aim of producing rapid point-of-care detectors (90). A small 
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number of sensors utilise graphene as a platform due to the ease of lipid mono- 
and bilayer formation on graphene, through non-covalent hydrophobic 
interactions between the lipids and the graphene whilst maintaining the desired 
properties of graphene. Liu et al. have developed a fluorescence biosensor to 
detect phospholipase D activity, an enzyme that catalyses the hydrolysis of the 
phospholipid, phosphatidylcholine into choline and phosphatic acid, important for 
understanding and regulating many biological processes (91). Other research 
has been conducted investigating bactericidal activity of antimicrobial peptides 
on neutral POPC, negatively charged POPC:POPG (2:1) and positively charged 
DOPC:DOTAP (2:1) bilayers (88). In the majority of these studies, bilayers were 
formed by vesicle fusion, leading to concerns about the integrity and uniformity 
of the layers. In this research we used the Langmuir-Blodgett technique to 
address these problems.  
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2.2 Experimental Methods 
	
	
2.2.1 Glassware Preparation 
	
All beakers used were first cleaned using Decon 90, then rinsed and sonicated 
with deionised water for 20 mins (Ultrawave Sonicator). This was then followed 
by rinsing and sonication in ethanol for a further 20 mins. Once sonication ended, 
the ethanol was disposed of, and the beakers were dried in a hot oven. The 
Hamilton syringe and glass vials, which were used to store lipids, were cleaned, 
firstly with deionised water followed by methanol then chloroform. With each cycle 
of cleaning, 5 – 10 rinses of the syringe were carried out.	
	
	
2.2.2 Preparation and Characterisation of Graphene Oxide Suspension  
	
Graphene oxide dry platelets (Graphene Supermarket, flake size 0.5 – 5 µm, 
thickness 1.1 ± 0.2 nm, 79% carbon 20% oxygen) were dispersed in nanopure 
water (18.2 MΩ) giving a 6 mg/ml concentration of graphene oxide (in order to 
achieve a concentration of 0.1 mg/ml once added to the subphase of the trough). 
The graphene oxide was sonicated for 1h, then centrifuged at 10,000 rpm for 10 
minutes, to remove any aggregated graphene. The graphene oxide flakes were 
characteristed using scanning electron microscopy (FEI NanoBeam, SEM) on a 
metal substrate, Raman spectroscopy (Witec Alpha300 R Raman Imaging 
System) and atomic force microscopy (NT-MDT, Ntegra Aura).  
To record Fourier Transform – Infrared (FT-IR) spectra of GO, the GO 
sample was prepared using the KBr disc technique. GO flakes were mixed with 
dry KBr powder (approximately 0.2 – 1 % of total mass GO) using a pestle and 
mortar and poured into the sample holder. The KBr disk was pressed using a 
hydraulic press. The KBr disk was then inserted into the IR sample holder and 
the spectra were ran using an IRTracer-100 in transmittance mode. The spectra 
were recorded using LabsolutionsIR software. 
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2.2.3 Microelectrophoresis of Graphene Oxide 
 
To determine the charge of the GO flakes, a flow chamber was adapted for 
microelectrophoresis measurements [Figure 2.8]. The flow chamber was set up 
on a microscope stage. 150 µl of 1 mg/ml GO solution in water was added to the 
flow chamber and allowed 10 mins to settle.  
 
	
Figure 2.8 The flow chamber with the GO solution flowing between the two electrodes. By 
applying a voltage across the two electrodes, the charge of the GO flakes can be 
determined by tracking the direction of movement of the flakes.  
The two electrodes were placed in opposite sides of the chamber, ensuring full 
contact with the GO solution. A voltage of 2V was applied across the two 
electrodes. Videos were then recorded using bright-filed microscopy (Leica 
DMFLS, 63X objective) to track the direction of movement of the graphene oxide 
flakes.  
 
 
2.2.4 Lipid Preparation for Langmuir Monolayer 
	
All lipid solutions were stored in glass vials sealed with Parafilm at a temperature 
of approximately -20°C. Various compositions of lipid mixture were used in this 
series of experiments. Lipid mixtures that best represent the lipid compositions of 
the inner and outer leaflets of biological membranes were used for the first set of 
experiments. These mixtures were delivered in chloroform to assure a 
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homogenous mixture, at a concentration of 1 mg/ml (Avanti Polar Lipids). The 
lipid solutions were used as supplied. The lipid compositions used are given in 
Table 2.1.  
	
Lipid Inner Leaflet % (w/w) Outer Leaflet % (w/w) 
16:0 PS 22.3 0 
16:0 PC 11.8 15.1 
16:0 PE 38 48.7 
Cholesterol 20 25.6 
16:0 SM 8.3 10.3 
 
Table 2.1 The different lipid compositions of the inner and outer leaflet mixtures; 16:0 PS 
(1,2-dipalmitoyl-sn-glycero-3-phosphoserine); 16:0 PC (1,2-dipalmitoyl-sn-glycero-3-
phosphocholine); 16:0 PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine); 
cholesterol; 16:0 SM (N-palmitoyl-D-erythro-sphingosylphosphorylcholine). 
	
	
2.2.5 Langmuir Trough Preparation 
	
All measurements were carried out using a Kibron µ-trough (45 mm X 131 mm) 
with two moveable barriers, and Filmware version 2.41 software. The Langmuir 
trough and barriers were first cleaned and polished to remove any scratches from 
the surface. This was done using lapping glass and mild detergent. The scratches 
were removed from all surfaces, by gently moving the trough and barriers over 
the lapping glass, with frequent washing with pure water. The Langmuir trough 
was then rinsed in ethanol, and contaminants were removed using a HFC 
(hydofluorocarbon) free air duster. The trough was then placed in the holder, 
underneath the sensor arm. A magnet, attached to a stirrer plate, was placed 
underneath the trough, and a magnetic flea in the middle of the trough. This was 
set at a speed of 180 rpm. The same cleaning and lapping process as used for 
the trough was applied to the barriers. The trough was filled with approximately 
60 ml of nanopure water. The sensor probe, stored in ethanol, was run through a 
flame to remove any contaminates. This was repeated a few times. The probe 
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was then attached to the sensor arm, and lowered into the water subphase and 
calibrated according to the manufacturer’s instructions. The barriers were 
initialised to determine the trough edge, and hence the greatest surface area of 
the trough. The trough surface was cleaned by repeated sweeps of the barriers 
across the surface, followed by aspiration of the surface using a hypodermic 
needle attached to a vacuum pump whilst the barriers were at minimum 
separation. This process was repeated until there was no further change in 
surface pressure with barrier compression. The probe was then re-zeroed. Once 
the surface was clean, the lipid solution was then spread on the surface. The lipid 
solution was deposited onto the surface using a Hamilton syringe. Volumes 
between 10 – 25 μl of chloroform containing 1 mg/ml of lipid were added 
depending on the lipid being used. To deposit the lipids, firstly, a small droplet 
was formed on the end of the syringe, no bigger than 1 μl. Then, gently, the end 
of the syringe was pressed onto the surface, ensuring lipids were not added too 
close to the barriers, trough edges and the probe. This prevented build-up of lipids 
on these surfaces. It is important to deposit small volumes of lipid at a time 
because if the droplet is too big, it could sink through the surface, depositing the 
lipids on the bottom of the trough. After the required volume of lipid had been 
added to the surface, the monolayer was then left to equilibrate for 15 min. This 
allowed sufficient time for all the solvent to evaporate.  
	
	
2.2.6 Recording π – A Isotherms 
	
π-A isotherms were constructed by compression and relaxation of the barriers at 
a rate of 0.5 Å2/molecule/min. The optimum rate was determined after testing a 
range of rates. At a faster rate, smaller details of the isotherms were not being 
picked up, noticeably, missing the phase transitions. Cycles of compressions and 
relaxation were repeated until a reproducible trace of the isotherm was achieved. 
This is indicative of a stable monolayer, meaning the graphene oxide may now 
be incorporated into the lipid monolayer.  
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2.2.7 Incorporating Graphene Oxide into the Lipid Monolayer 
	
To incorporate the GO into the monolayer, the GO solution was injected 
underneath the barriers into the subphase of the trough using a 1 ml syringe with 
needle attachment, after the monolayer had equilibrated at a chosen constant 
pressure.	 Initially experiments were carried out using 1 mg/ml GO solution in 
order to achieve a 0.05 mg/ml concentration inside the trough, however, this 
required using approximately 3 ml of solution which caused leaking at the edges 
of the trough. Therefore, it was decided that an optimum volume would have to 
be between 0.5 – 1 ml, arriving at the decision to use 1ml of a 6 mg/ml GO 
solution, to give a 0.1 mg/ml concentration in the trough. After addition of GO the 
system was held at a constant pressure and subsequent changes in trough area 
were recorded. After area had stabilised pressure-area isotherms were recorded, 
starting in the direction of increasing surface pressure. Generally, 3-4 
compression-relaxation cycles were performed. 
	
	
2.2.8 Lipid Preparation for Langmuir – Blodgett Deposition 
	
Only lipid mixtures that do not form domains were employed in these experiments 
to ensure uniformity of the films. Details of these are given in Table 2.2.  
	
Substrate Lipid used (Avanti Polar Lipids) 
Silicon DPPC 
HOPG DPPC:Chol (80:20) 
DPPC 
BDD DPPC 
DOPC 
DOPC:DPPC (1:1) 
	
Table 2.2 The different substrates used for Langmuir-Blodgett deposition, and the different 
lipids deposited. 
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Cholesterol solutions were prepared by dissolving cholesterol powder in 
chloroform, to a concentration of 1 mg/ml.  
	
	
2.2.9 Substrate Cleaning 
	
Lipid mono- and bilayers were deposited onto a range of different carbon 
materials, including boron-doped diamond (BDD, Diamond Detectors Ltd., Poole 
UK, boron acceptor concentration ≥ 1020 cm-3) (9.6 cm2) and highly-oriented 
pyrolytic graphite (HOPG) (10X10X1, 2 mm3, NT-MDT Co., Moscow). Silicon (p+-
doped Si with 300 nm SiO2 coating, IDB Technologies) was also used as a 
substrate in preliminary experiments. Silicon substrates were cleaned using 
successive sonication steps. Firstly, the substrates were sonicated for 30 min in 
acetone, then for 20 min in nanopure water, and finally 15 min in isopropanol. 
The substrates were then dried using a steady flow of nitrogen. HOPG substrates 
were cleaned using the “cleaving” method. This was performed by using tape to 
stick to the dirty surface of the HOPG and peel off the top layer of carbon, leaving 
a clean surface underneath. BDD substrates were cleaned, first by rinsing with 
water, then methanol and finally polished using alumina slurry (0.3 μM, 0.05 μM, 
Sigma Aldrich, UK).  
	
	
2.2.10 Lipid Deposition 
	
The Langmuir trough was set up as previously described [Section 2.2.4]. Silicon, 
a hydrophilic substrate, attached to a dipping arm, was lowered into a nanopure 
water subphase. The lipid solution was then added to the surface. Once a stable 
lipid monolayer was established, a π-A isotherm was constructed and the film 
was set at the required surface pressure. The feedback system was then set to 
maintain this pressure during dipping. The pressure was generally maintained at 
30 mN/m to approximate the packing density found in biological membranes. The 
substrate, attached to the dipping arm, was then raised through the lipid 
monolayer at a rate of 1 mm/min to deposit a monolayer. The substrate was then 
left to air-dry 15 minutes before depositing a second layer by lowering the 
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substrate back through the monolayer at the same rate. Once fully immersed in 
the subphase, the surface was cleaned by repeated aspiration until surface 
pressure returned to zero in order to remove the lipid monolayer from the surface 
before raising the substrate out of the substrate, to prevent further lipid 
deposition. 
Because the BDD substrate was too large (3.5 cm diameter, 9.6 cm2 area) 
to be dipped into the trough, the Langmuir-Schaefer method was used to deposit 
monolayers. In this approach, lipid layers were deposited onto the substrate 
through dipping horizontally, rather than vertically (92). 
As HOPG is naturally hydrophobic, a lipid monolayer with the fatty acid 
tails adhering to the substrate was deposited by setting up the trough with the 
HOPG poised above the lipid monolayer, and then lowered through the film at a 
rate of 1 mm/min. The surface was then cleaned to reach a surface pressure of 
zero, and then the HOPG was removed from the subphase. No attempt was 
made to assemble an inverted bilayer. However, normal bilayers were assembled 
as for silicon on HOPG rendered hydrophilic by anodic polarization. For this, the 
HOPG was held in the electrochemical cell, filled with 0.1 M NaOH solution at 
1500 mV for 3 min.  
	
	
2.2.11 Surface Characterisation 
	
For all the bilayers and monolayers, the deposition ratio, 𝜏, was calculated by 
measuring the change in trough area before deposition and after deposition (93) 
 
 𝜏 = 	𝐴% 𝐴" 
 
 
(2.4) 
where Al is the decrease in the area of the trough and As is the coated area of 
the solid substrate. The deposition ratio was used to characterise the transfer of 
layer. When the deposition ratio is equal to one, the transfer has been complete. 
Wetting properties were analysed using a stereo microscope (used horizontally) 
attached to a CCD camera (AVT Marlin) and a syringe which was used to release 
a water droplet on the substrate surface. The contact angle was measured as the 
angle formed between the substrate and the edge of the water droplet.   
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Atomic force microscopy (AFM) was also used for characterisation of the 
mono- and bilayers on silicon substrates. DPPC Lipid mono- and bilayers were 
deposited onto half of the silicon substrates in order to form a step height between 
the surface and the lipids. An AFM (NT-MDT, Ntegra Aura) was used at room 
temperature in semi-contact mode to detect surface topographical changes. AFM 
was also used to determine surface roughness of HOPG and BDD substrates.  
	
	
2.2.12 Measurement of Electrochemical Properties of Lipid Films 
	
To determine the electrochemical properties for all substrates (BDD and HOPG), 
the same method was used. A three-electrode system was used for all 
measurements. The substrate with lipid layer adsorbed was placed on an 
electrical contact, and inserted in the bottom of the electrochemical cell [Figure 
2.9]. The cell was filled with a solution containing the electroactive solute, 
ensuring no bubbles form in the cell. Both ruthenium hexamine [Ru(NH3)6]
3+/2+ 
and ferricyanide ([Fe(CN)6]3−/4-) were used as electroactive probe molecules at a 
1mmol concentration in 0.2M KCl, ruthenium being used for the bulk of the 
experiments as it was found to be more stable over time. This thesis has not 
explored the charge structure of membrane pores where choice of electrolyte is 
important, where both species would need to be compared. 
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Figure 2.9 Experimental set up of the electrochemical cell, showing the 3-electrode system. 
The substrates used in these experiments are held in place between the O-ring and the 
electrical contact. 
The electrodes used in this experiment were an Ag/AgCl reference electrode 
(BASi) with a salt bridge containing 3M NaCl (Sigma Aldrich, UK) and a platinum 
counter electrode (BASi) of curled wire for greater surface area. Nitrogen was 
bubbled through the electrolyte solution for 10 minutes to remove oxygen. 
Measurements were performed on a Bas100W electrochemical analyser. A scan 
rate of 50 mV/s was used, over a potential scan of -0.8 V – 0.6 V. 
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2.3 Results and Discussion 
	
	
This section includes all Langmuir trough results for graphene oxide interacting 
with inner and outer leaflet lipid mixtures, the π-A isotherms and dilational 
modulus. It also includes results from the Langmuir-Blodgett deposition of lipid 
mono- and bilayers onto different substrates, and their electrochemical response.  
	
 
2.3.1 Characterisation of Graphene Oxide 
	
For all experiments the same method for producing graphene oxide suspensions 
was used [Section 2.2.2].  
 Raman spectroscopy was one of the methods used to characterise the 
GO. GO has two characteristic Raman peaks, the G-peak (1580 cm-1) and the D-
peak (1350 cm-1), which relates to the honeycomb lattice of carbon atoms and 
defects in the crystal (predominantly, the oxygen groups), respectively. A typical 
Raman spectrum obtained for the GO samples is shown in Figure 2.10. 
	
 
Figure 2.10 A typical Raman spectrum obtained for GO showing its two characteristic 
peaks at 1351 cm-1 (D-peak) and 1584 cm-1 (G-peak). 
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The Raman spectrum shows the D-peak at 1351 cm-1 and the G-peak at 1584 
cm-1.  
Scanning electron microscopy (SEM) was used to determine the average 
size of the flakes produced. An example of the SEM images obtained is shown 
in Figure 1.3. The graphene oxide is distinguished by the dark grey flakes. Figure 
2.11 shows the histogram of size distribution of GO flakes suspended in nanopure 
water.  
 
 
 
Figure 2.11 Histogram of the size distribution for 0.1 mg/ml GO suspension, centrifuged 
for 10,000 rpm for 10 min. 
The analysis of 250 GO flakes gives an average size of ~ 0.5 µm (the size is 
measured according to the length of the major axis).  
 To determine the average thickness of the GO flakes produced, atomic 
force microscopy (AFM) was used. Height profiles were taken across various 
cross sections of GO flakes (n=100) [Figure 2.12].  
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a) 
 
 
b) 
	
 
Figure 2.12 a) 50 x 50 µm AFM image scan of 0.1 mg/ml GO giving examples of the cross-
sections taken for height analysis b) examples of height profiles taken across GO flakes.  
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Height profiles of 100 GO flakes were taken giving an average thickness of ~ 13 
nm [Figure 2.13]. 
	
Figure 2.13 Histogram of the thickness distribution for 0.1 mg/ml GO suspension, 
centrifuged for 10,000 rpm for 10 min. 
The expected thickness was 1.1 ± 0.2 nm (the recorded thickness provided with 
the data sheet: Graphene Supermarket), however the AFM used for this analysis 
was unable to resolve below 5 nm so it was not possible to analyse flakes of the 
expected thickness. 
The chemical composition of the GO samples used can be determined 
using FT–IR spectroscopy, due to its characteristic IR Spectrum. Figure 2.14 
shows the typical FTIR spectrum obtained. Characteristic features of the 
spectrum are shown at 3420 cm-1 (O–H), 1719 cm-1 (C=O from carbonyl and 
carboxyl groups), 1612 cm-1 (C=C from aromatic carbons), 1049 cm-1 and 1198 
cm-1 (C–O from alkoxy and epoxy groups) as expected from previous literature 
(94) (95) (96). The FTIR spectrum provides information of the presence of 
different functional groups across the GO surface. 
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Figure 2.14 FTIR spectrum of graphene oxide, showing the presence of different oxygen-
containing functional groups.  
 
 
2.3.2 Surface Charge of Graphene Oxide 
 
Microelectrophoresis was used to determine the charge of the graphene oxide by 
tracking the motion of the dispersed charged particles relative to a fluid under the 
influence of an electric field. Videos of the GO flakes were recorded showing an 
overall migration of flakes towards the cathode, determining GO to be negatively 
charged. The overall surface charge of the GO is calculated by determining the 
drag force of the GO flakes through solution relative to the applied voltage. The 
drag force is calculated using  
 𝐹T = 𝑝𝜏𝐴 
 
 
 (2.5) 
where 𝐹Tis the drag force, 𝑝 is the density of the fluid, 𝜏 is the shear stress (“drag”) 
in the fluid and A is the average area of the GO flakes. To calculate 𝜏, Equation 
2.6 is used  
 𝜏 = 	𝐶T𝑝𝑣Q2   (2.6) 
where 𝐶T is the drag coefficient and 𝑣 is the calculated velocity of the GO flakes. 𝐶T is defined as 0.074(𝑅𝑒)\]/N where 𝑅𝑒 is the Reynolds number 
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 𝑅𝑒 = 	𝜌𝜈𝐿𝜇  
 
 
(2.7) 
and 𝐿 is the average length of GO flake and 𝜇 is the viscosity of water. Once the 
force has been calculated it can be used to determine the total charge, 𝑞 
 
 𝐹 = 𝑞 𝑉Q𝑑   (2.8) 
where 𝑉 is the applied voltage and 𝑑 is the distance between the two electrodes. 
The average total charge calculated for GO (n=30) was 1.61 ± 0.88 x 10-16 C per 
flake.  
 
 
2.3.3 Langmuir Monolayer π – A Isotherms 
	
Figure 2.15 shows the π-A isotherms of the lipid mixtures representative 
of the inner and outer leaflet of the cell membrane [Table 2.1]. The isotherms are 
distinctively different. The inner leaflet has a steeper gradient and appears as a 
smoother curve. For both isotherms a clear first order transition occurs, shown 
by a plateau in the isotherms, indicating a phase transition. However, this 
transition is extended for the outer leaflet, and occurs at a higher area per 
molecule. The phase transition for the inner leaflet also occurs at a lower 
pressure. The inner leaflet has a higher compressibility as shown by the dilational 
modulus. It is possible that the addition of PS in the mixture could increase the 
stability of domain structures, partially due to the unusual bonding that occurs 
between PS molecules which overcomes repulsive electrostatic forces between 
the negatively charge head groups (97).  
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Figure 2.15 Pressure (mN/m) vs Area per lipid (Å2) isotherms (left) comparing inner (black) 
and outer (blue) lipid mixtures, with the corresponding dilational modulus (right). 
The isotherms reported here are in good agreement with previously recorded 
isotherms for the inner and outer membrane leaflets (98).  
 In order to characterise the effects of the graphene oxide – lipid interaction, 
π-A isotherms were investigated for the different lipid systems after addition of 
graphene oxide to the subphase. In all experiments of this type, the monolayer 
was first compressed and relaxed a few times, to ensure a reproducible isotherm. 
The graphene oxide was then added to the subphase at pressures either at which 
the monolayer was undergoing its phase transition (~ 10 – 20 mN/m) or when the 
monolayer was in a compressed state (~ 20 – 30 mN/m). The system is then 
given a 15 minute equilibration period, whilst the subphase was continuously 
stirred, before relaxation and compression of the monolayer with the presence of 
graphene oxide.  
Figures 2.16 and 2.17 show the change in trough area recorded for one 
experiment during addition of the graphene oxide, at constant pressure, to the 
inner and outer leaflet monolayers, respectively. All results recorded (n=5 for 
each experiment) show an increase in area, which is presumed to arise from 
graphene oxide insertion in the monolayer.  
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Figure 2.16 Time vs area per molecule comparing the change in area observed during 
addition of graphene oxide at 17 mN/m (black) and 20 mN/m (red) to the inner leaflet 
monolayer. Graphene oxide was added at t=0 after the monolayer had equilibrated for 15 
min. 
 
Figure 2.17 Time vs area per molecule comparing the change in area observed during 
addition of graphene oxide at 18.5 mN/m (black) and 25 mN/m (red) to the outer leaflet 
monolayer. Graphene oxide was added at t=0 after the monolayer had equilibrated for 15 
min. 
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For both monolayers there is a greater increase in area when graphene 
oxide is added at the phase transition. At the phase transition, the lipids are less 
densely packed, meaning the monolayer is more permeable to graphene oxide. 
Penetration allows possible interactions between the head groups of the 
phospholipids and also the fatty acid tails.  A change in area of 2.1 Å2 was 
recorded at the inner leaflet monolayer and 1.85 Å2 at the outer monolayer. A 
slightly greater change in area was observed at the inner leaflet monolayer. This 
may arise from repulsive forces between the oxygen-containing groups on the 
graphene oxide, and the negatively charged PS head groups. 
The proposed mechanisms of GO insertion are given in Figure 2.18 
showing the increase in trough area on addition of GO to the inner and outer 
monolayers at the phase transition. It is important to note at this stage, an 
investigation into the orientation of GO has not been conducted. The proposed 
mechanisms show examples of both ‘edge-on’ and ‘face-on’ GO.  
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Figure 2.18 The addition of GO at the monolayer phase transition for a) inner membrane 
leaflet and b) outer membrane leaflet and the resulting change in trough area. A greater 
increase in area is observed for the inner leaflet, possibly due to repulsive forces between 
the negatively charged lipids and GO.  
 
a) 
b) 
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At the condensed phase a change in area of 0.57 Å2 at the inner 
monolayer, and 0.7 Å2 at the outer monolayer, was observed. When the 
monolayer is in a condensed phase the graphene oxide can only interact with the 
lipid head groups. The change in area observed at the inner monolayer is less 
than at the outer. This suggests less graphene oxide is inserted into the 
monolayer, possibly due to a more concentrated overall negative charge from the 
PS head groups repelling the graphene. Figures 2.19 and 2.20 show the 
proposed interactions of GO with the inner and outer membrane leaflet, 
respectively.  
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Figure 2.19 The addition of GO to the inner leaflet monolayer at the condensed phase. The 
GO interacts with the neutral lipid head groups, with negatively charged lipid head groups 
repelling some GO forcing it away from the surface. Only a small increase in area is 
observed, as the monolayer is more tightly packed and harder for the GO to penetrate.  
	
Figure 2.20 The addition of GO to the outer leaflet monolayer at the condensed phase. 
There is a greater increase in area compared to the inner leaflet monolayer due to the 
absence of the negatively charged lipid head groups, however, the increase in area is still 
small due to the condensed packing of the lipids.   
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After addition of graphene oxide, and re-equilibration of pressure, the 
monolayer was then relaxed and subsequent cycles of compression and 
relaxation are performed in order to record reproducible isotherms. The results 
presented here are examples to show the general trends of the π-A isotherms 
recorded throughout multiple experiments (n=5 for each experiment). Figure 2.21 
shows the π-A isotherms and the dilational modulus for the inner leaflet, with 
graphene oxide added at 17 mN/m, the phase transition pressure. The presence 
of graphene oxide increases the overall pressure of the system. The plateau 
region observed in the isotherm recorded with graphene shifts to a higher area 
per molecule and shows an extended phase transition, indicating either additional 
graphene oxide insertion into the monolayer or stronger lipid-graphene 
interactions. The difference in gradient between the isotherms suggests 
graphene oxide inserts in between the lipid molecules interacting with the head 
groups on the surface, decreasing the compressibility of the monolayer. The 
dilational modulus confirms a significant decrease in the compressibility of the 
monolayer in the presence of graphene oxide. A further decrease in the dilational 
modulus at ~ 45 mN/m shows the monolayer is beginning to collapse. It appears 
the addition of graphene oxide produces a ‘harder’ monolayer under 
compression, resulting in the reduced values for the dilational modulus, possibly 
due to graphene oxide interfering with the packing of the lipid tails or the graphene 
itself is being extruded from the monolayer. The proposed interactions are given 
in Figure 2.22.   
Figure 2.23 shows the π-A isotherms and dilational modulus for the inner 
leaflet with graphene oxide added at 20 mN/m, the condensed phase pressure. 
The isotherms are less smooth, indicating more complex phase behaviour, with 
inflections around 30 – 35 mN/m. Analysis of the isotherms recorded and the 
corresponding dilational modulus curves shows the addition of graphene oxide 
increases the overall pressure and decreases the compressibility, but to a lesser 
extent than when graphene oxide is added at the phase transition where there is 
more graphene oxide inserted in the monolayer. No changes in the isotherms are 
observed with repeated compression and relaxation of the monolayer, with no 
further graphene oxide inserting in the monolayer. This would suggest an initial 
interaction of graphene oxide with the lipid head groups, which reaches saturation 
[Figure 2.24].   
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Figure 2.21 Pressure-Area isotherms (left) and Dilational modulus vs surface pressure 
(right) comparing a pure inner leaflet mixture (black) with inner leaflet with graphene oxide 
incorporated at a constant pressure of 17 mN/m (blue). 
 
 
Figure 2.22 Proposed GO interactions with the inner monolayer at the phase transition. 
Once the GO is added at the phase transition, the barriers are relaxed and compressed. 
Due to the repulsive forces between the GO and negatively charged lipids, there is greater 
difficulty compressing the monolayer, and the lipids are less densely packed.  
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Figure 2.23 Pressure-Area isotherms (left) and Dilational modulus vs surface pressure 
(right) comparing a pure inner leaflet mixture (black) with inner leaflet with graphene oxide 
incorporated at a constant pressure of 20 mN/m (blue). 
 
Figure 2.24 Proposed GO interactions with the inner monolayer at the condensed phase. 
Less GO is incorporated into the monolayer at the condensed phase. There is an initial 
interaction with GO and neutral lipids, with negatively charged lipids repulsing the 
remaining GO. As the barriers relax remaining GO sinks to the bottom of trough.  
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Figures 2.25 and 2.27 show the π-A isotherms and dilational modulus recorded 
for the outer leaflet monolayer with graphene oxide addition at 20.5 mN/m and 30 
mN/m, respectively. In contrast to the results reported for the inner membrane 
leaflet, results were similar for different initial monolayer pressures. For both the 
phase transition and condensed pressure the initial relaxed pressure increases 
by ~ 5.5 ± 0.5 mN/m. This suggests that, although the initial change in area during 
graphene oxide addition was lower at the condensed pressure than at the phase 
transition, the same amount of graphene oxide has been inserted into the 
monolayer. It is possible that the graphene oxide is interacting weakly with the 
head groups of at least some components of the mixture, which in turn allowed 
for more graphene oxide insertion on the first relaxation of the monolayer. Since 
this was not shown for the inner leaflet, it is probable that PS is a significant 
determinant of graphene oxide insertion. The change in dilational modulus 
supports this hypothesis showing a compressibility of ~ 400 mN/mm before 
graphene oxide insertion, and ~ 350 mN/mm after for both experiments. Thus, 
the addition of graphene oxide decreases the compressibility, but not as 
dramatically as for the inner leaflet. The proposed mechanisms are given in 
Figure 2.26 and 2.28.  
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Figure 2.25 Pressure-Area isotherms (left) and Dilational modulus vs surface pressure 
(right) comparing a pure outer leaflet mixture (black) with outer leaflet with graphene oxide 
incorporated at a constant pressure of 20.5 mN/m (blue). 
 
Figure 2.26 Proposed GO interactions with the outer monolayer at the phase transition. 
The outer leaflet is more compressible than the inner leaflet  after addition of GO  due to 
the absence of repulsive forces from PS lipids. Three possible interactions are proposed: 
GO can either be interacting with the lipid head groups; the fatty acid tails; or being 
extruded from the monolayer, affecting the molecular packing of the monolayer. 
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Figure 2.27 Pressure-Area isotherms (left) and Dilational modulus vs surface pressure 
(right) comparing a pure outer leaflet mixture (black) with outer leaflet with graphene oxide 
incorporated at a constant pressure of 28 mN/m (blue). 
 
Figure 2.28 Proposed GO interactions with the outer monolayer at the condensed phase. 
It is proposed that GO is interacting weakly with the monolayer at constant pressure. 
Relaxation of the monolayer can incorporate further GO into the monolayer, due to the 
absence of repulsive forces. The compressibility is then equivalent to when the GO is 
added at the phase transition.   
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In the Langmuir monolayers (and vesicles and cells) GO flakes can orient 
either parallel or perpendicular to the plane of phospholipids and may or may not 
penetrate the bilayer. It is important to distinguish these modes of interaction and 
so a series of experiments were undertaken in which the phospholipid head 
groups were allowed to interact only with carbon planes. An important corollary 
of this work is that the layers formed could be used as a receptor in the 
development of electrochemical sensors. For this series of experiments, the 
Langmuir-Blodgett approach was used.  
 
 
2.3.4 Langmuir – Blodgett Deposition and Characterisation of Lipid Layers on 
Silicon 
	
In order to develop the methodology for Langmuir-Blodgett deposition of lipid 
layers onto carbon substrates and characterisation of the layers, DPPC 
monolayers were first deposited onto silicon substrates. For all layers deposited 
an average deposition ratio of 1.3 ± 0.3 (n=11) was calculated, at an optimum 
deposition rate of 1 mm/min. Wettability experiments were carried out to 
determine the nature of the silicon substrate and the orientation of the lipid 
monolayer deposited. Wettability of the bare silicon substrate gave a contact 
angle of ~ 15° indicating a hydrophilic surface.  After deposition of a lipid 
monolayer, a contact angle of ~ 65° was calculated showing the modified silicon 
surface to be hydrophobic [Figure 2.29]. This is expected due to the hydrophilic 
head groups of the lipids interacting with the silicon surface, leaving the 
hydrophobic tails exposed. The contact angles calculated were consistent over 
the surface of the substrate, suggesting uniform layers had been deposited.  
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Figure 2.29 Images showing a silicon substrate (left) and monolayer deposited (right) on 
the surface. The water droplet technique was used to determine the wettability of the 
substrate. The left shown to be hydrophilic, and the right hydrophobic. 
AFM was used to give a height profile of the sample to determine the thickness 
of the lipid layers. The difference in height between the bare silicon and the lipid 
DPPC monolayer deposited was shown to be 2.39 nm [Figure 2.30].  
 
 
Figure 2.30 AFM image of a lipid monolayer deposited (right) onto a silicon substrate (left), 
with corresponding cross-section profile shown by the black line. The arrows indicate the 
points taken to determine the step height. 
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The average length of a phospholipid is ~ 2 nm, so the AFM result correlates well 
for a lipid monolayer deposited with lipids perpendicular to the substrate surface 
[Figure 2.31].  
	
Figure 2.31 The predicted arrangement of a phospholipid monolayer deposited onto a 
silicon substrate 
However, surface heterogeneities can be observed in the surface profile, as well 
as the image generated from the AFM scan. The image shows uniformity across 
a large surface area of the substrate, but there are obvious holes where the lipid 
has not been deposited, possibly due to surface defects which can be observed 
on the bare silicon wafer.   
	
	
2.3.5 Electrochemical Analysis of Lipid Layers Deposited onto BDD 
	
Lipid layers were deposited onto BDD and HOPG substrates: firstly, to determine 
whether lipid layers are deposited and if this can be characterised 
electrochemically, and secondly, to determine the sensitivity of the layer to the 
substrate used. First, DOPC, DPPC and DOPC:DPPC monolayers were 
deposited onto clean BDD substrates. For all monolayers an average deposition 
ratio of 1.4 ± 0.3 (n=13) was calculated, suggesting a uniform layer was 
deposited. Figure 2.32 shows the voltammetric response of [Fe(CN)6]3−/4- at the 
BDD electrode with these monolayer deposited. For all bare electrode 
measurements, well defined anodic and cathodic peaks are observed. For all 
voltammograms, GHIGHJ	 = ~ 1, except in the case of DPPC where complete blockage 
of electron transfer occurred. The voltammograms show a decrease in electron 
transfer from the bare BDD to BDD – DPPC. This could be due to the molecular 
packing on the substrate. DPPC is likely to pack efficiently on the surface due to 
its structure, consisting of two saturated hydrocarbon chains. DOPC molecules 
have one unsaturated bond in one of the hydrocarbon chains, which causes a 
kink in the tail preventing close packing between molecules. For DOPC, the 
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peaks are only slightly smaller than bare BDD, with 	∆𝐸H = 185 mV. It is likely, 
therefore, that very little DOPC has been deposited onto the surface, leaving a 
significant area of the electrode available for electrolyte to react. The 
DOPC:DPPC monolayer shows a larger peak potential 	∆𝐸H = 348 mV, indicating 
slower kinetics. 
	
	
Figure 2.32 Cyclic voltammogram in 1 M KCl containing 1 mM [Fe(CN)6]3−/4-. Black – bare 
BDD electrode, Red – DOPC monolayer, Blue – DOPC:DPPC (1:1) monolayer, Green – 
DPPC monolayer 
It has been previously reported by Ru et al. that DPPC molecules form a more 
continuous membrane on reduced graphene oxide sheets, using the Langmuir-
Blodgett technique, compared to DOPC (99), possibly because DPPC is in a gel 
phase at room temperature whereas DOPC is a liquid phase and is more 
disordered.  
 A limitation of these experiments was the stability of the ferricyanide 
probe, which showed changes in the electrochemical response on bare BDD over 
longer time periods. At this stage, the charge structure of the electroactive 
species is not important so ruthenium hexamine was used for subsequent 
experiments (choice of redox probe is important for understanding charge 
structures of pores that form in the monolayers). Another limitation was the size 
and surface roughness of the BDD substrate which presents difficulties for 
uniform deposition of lipid layers. The size of BDD used in these experiments was 
9.6 cm2. For successful deposition of a monolayer, the transfer ratio should be 
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equal to 1, and so the area required of the Langmuir monolayer was a significant 
fraction of that of the trough used in these experiments. AFM analysis of BDD at 
various points across the substrate showed the surface to be rough, with a height 
range of 0 – 120 nm (60X the height of a phospholipid) [Figure 2.33]. This surface 
morphology is typical of BDD (100), however, for Langmuir-Blodgett deposition a 
smooth surface is required (101).  
 
	
	
Figure 2.33 AFM topographical images of BDD at different points across the surface of the 
substrate. 2 dimensional view 10 x 10 µm scan. Colour range from black – white: 0 – 120 
nm. 
	
	
2.3.6 Electrochemical Analysis of Lipid Layers Deposited onto HOPG 
	
As BDD was shown to be an unsuitable substrate for Langmuir-Blodgett 
deposition, HOPG was used to further investigate phospholipid interactions with 
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carbon substrates. To deposit a bilayer comparable to a cell membrane, the 
substrate initially has to be hydrophilic. The following experiments were 
conducted with hydrophilic HOPG. The predicted arrangement of the lipid bilayer 
on HOPG is shown in Figure 2.34. 
 
 
 
Figure 2.34 The predicted orientation of a phospholipid bilayer on a hydrophobic HOPG 
substrate, and hydrophilic HOPG. 
The HOPG electrode was polarised at 1500 mV in 0.1 M NaOH, which causes 
the addition of surface oxygen, making the surface more hydrophilic (102).  For 
all layers deposited an average deposition ratio of 1.00 ± 0.2 (n=9) was 
calculated. Figure 2.35 shows an example of one cyclic voltammogram of 
Ru(NH3)6 3+/2+ at the bare HOPG substrate, and with a DPPC bilayer deposited. 
The peak heights decrease significantly, however, there is still some electron 
transfer occurring. 	∆𝐸H = 179, which suggests good kinetics i.e. the electrons can 
easily transfer between the solution and the electrode surface without anything 
on the surface blocking it. The dramatic decrease of the peak height suggests 
electron transfer is still occurring over a small fraction of the electrode surface, 
which indicates that there may be holes in the membrane.  
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Figure 2.35 Cyclic voltammogram in 1M KCl containing 1mM Ru(NH3)6 3+/2+ at a potential 
sweep rate of 50 mV/s at a bare HOPG electrode (blue) and at a HOPG electrode with a 
DPPC bilayer deposited (red). 
However, this was not a reproducible result, with repeat experiments showing 
great variation in the effects on electron transfer. Another example of a cyclic 
voltammogram produced depositing a DPPC bilayer onto HOPG is given in 
Figure 2.36, where there is a significant electron transfer occurring after bilayer 
deposition.  
	
	
Figure 2.36 Cyclic voltammogram in 1M KCl containing 1mM Ru(NH3)6 3+/2+ at a potential 
sweep rate of 50 mV/s at a bare HOPG electrode (blue) and at a HOPG electrode with a 
DPPC bilayer deposited (red). 
-500 -400 -300 -200 -100 0 100
Potential (mV) (vs Ag/AgCl)
-100
-80
-60
-40
-20
0
20
40
60
Cu
rre
nt
 (µ
A)
-500 -400 -300 -200 -100 0 100
Potential (mV) (vs Ag/AgCl)
-30
-20
-10
0
10
20
30
40
Cu
rre
nt
 (µ
A)
Langmuir Monolayer Studies and Langmuir-Blodgett Deposition 
 
 
	 99	
In order to form a more biologically relevant bilayer, a mixture of DPPC 
and Cholesterol, at a 80:20 molar ratio, was used in further experiments. Figure 
2.37 shows an example of a cyclic voltammogram of Ru(NH3)6 3+/2+ at the bare 
HOPG and with a DPPC:Chol bilayer deposited. A more complete coverage of 
the electrode is observed, significantly slowing electron transfer down, where 	∆𝐸H= 530. However, electron transfer has not been completely blocked, 
suggesting the electroactive species may be permeating the membrane.  
 
 
 
Figure 2.37 Cyclic voltammogram in 1M KCl containing 1mM Ru(NH3)6 3+/2+ at a potential 
sweep rate of 50 mV/s at a bare HOPG electrode (blue) and at a HOPG electrode with a 
DPPC:Cholesterol (1:1) bilayer deposited (red). 
It is possible for the cholesterol to decrease the permeability of the bilayer 
deposited. This could make the bilayer harder to permeate and consequently 
block more electron transfer, or slow down the process. However, as shown in 
Figure 2.38, the results observed in Figure 2.37 were not reproducible.  
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Figure 2.38 Cyclic voltammogram in 1M KCl containing 1mM Ru(NH3)6 3+/2+ at a potential 
sweep rate of 50 mV/s at a bare HOPG electrode (blue) and at a HOPG electrode with a 
DPPC:Cholesterol (1:1) bilayer deposited (red). 
The cyclic voltammetry reveals the HOPG – DPPC:Chol bilayer and BDD 
– DPPC monolayer act most effectively as barriers to the charge transfer between 
electrolyte solution and electrode surface. However, none were totally effective 
and there was considerable variability between experiments which probably 
reflected the difficulty in depositing a continuous, uniform layer. One difficulty 
using HOPG arose from changes to its surface with successive cleaving between 
each experiment. Cleaving HOPG can cause step defects on the surface, 
therefore leaving the HOPG with a rougher surface, which could affect lipid 
deposition and the uniformity of the layers. Heterogeneity across the surface 
could result in inconsistent lipid deposition. 
AFM scans of HOPG were taken at different cleaving steps to analyse the 
surface roughness of the substrate [Figure 2.39]. 
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Figure 2.39 AFM topographical images of HOPG at different stages of cleaving to show the 
differences in surface roughness. 2-dimensional view 10 x 10 µm scan. Colour range from 
black – white: 0 – 20 nm. 
The surface morphology showed a height range of 0 – 20 nm, with no 
significant difference between different stages of cleaving. This is a considerably 
smooth surface compared to BDD. The variability in electrochemical behaviour 
of BDD and HOPG results show no substrate is favourable to lipid deposition and, 
therefore, would suggest substrates smoothness is not a primary factor affecting 
lipid deposition. The transfer ratio for all experiments suggested uniform layers 
were deposited, however this was not shown in the electrochemical analysis. To 
successfully analyse the layers electrochemically to determine the arrangement 
of phospholipids on the substrates, and to finally develop a phospholipid 
biosensor, further investigation is required to determine the optimum conditions 
for lipid deposition and to identify any further external factors which could be 
affecting the electrochemical results.  
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2.4 Conclusions 
	
	
From Langmuir monolayer studies it has been possible to record π-A isotherms 
and calculate the corresponding dilational moduli for the inner and outer leaflet 
lipids, before and after the incorporation of graphene oxide. The inner leaflet 
mixture forms a more compressible monolayer, that reaches higher pressures at 
a lower area per molecule. It is likely that this is an effect of PS molecules present 
in the inner leaflet mixture, as the only difference between the two, possibly 
providing increased stabilisation to the organisation of the lipid molecules and 
lipid domains. On addition of graphene oxide, an increase in trough area is 
observed for all monolayers indicating graphene oxide insertion. For the inner 
leaflet, initial graphene oxide is dependent on pressure, with more graphene 
oxide insertion when added at the phase transition pressure. At the condensed 
phase pressure, less graphene oxide is able to permeate the monolayer, a 
possible result of repulsive forces between the negatively charged PS head 
groups and oxygen-containing groups on the graphene oxide.  For all isotherms 
recorded on addition of graphene oxide, there was an increase in the overall 
pressure of the monolayer, and a decrease in compressibility. It is likely that the 
graphene oxide is interacting with the head groups of the lipids, but there is a 
more significant interaction between the graphene oxide and PS lipids.  
 The Langmuir-Blodgett technique was used to deposit lipid layers onto 
BDD and HOPG substrates. These layers were analysed electrochemically in 
order to determine whether uniform lipid layers were deposited by measuring 
changes in electron transfer. This also has further potential to be used in 
biosensor applications. Although there was some success showing DPPC 
monolayers deposited onto BDD to completely block electron transfer, this result 
was not reproducible on HOPG. DPPC:DOPC and DOPC layers were also 
deposited onto BDD substrates, showing little effect on the electrochemistry. The 
results have shown unsuccessful deposition of uniform lipid mono- and bilayers, 
with incomplete coverage of carbon substrates, AFM analysis showed great 
difference in surface roughness but no significant difference in the 
electrochemical behaviour of either substrate, suggesting this was not the factor 
contributing to the unsuccessful results. Before developing a phospholipid 
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biosensor, further work is required to determine the optimum parameters for lipid 
deposition and to investigate any other external factors which could be 
contributing to the variable results. 
		
Chapter 3 The Effects of Graphene Oxide on Bilayer 
Vesicles 
	
	
This chapter will describe two groups of experiments, investigating the 
interactions of graphene oxide with lipid bilayer vesicles. In the first group, giant 
unilamellar vesicles are used to investigate permeability characterised by phase 
contrast microscopy. In the second group, changes in permeability are 
investigated using self-quenching fluorescent vesicles, pre-loaded with 
fluorescein, measuring the change in fluorescence intensity before and after 
graphene oxide exposure. In order to validate the methodology and to provide a 
comparator for the permeability changes, another group of experiments were 
undertaken using a range of known membrane-targeting toxins.  
	
	
3.1 Introduction 
	
	
Unilamellar lipid bilayer vesicles are an excellent model membrane system used 
for many biophysical and biochemical investigations (103). The vesicle is the 
closest artificial structure to that of a biological cell membrane. The simplest way 
to produce vesicles is by evaporating lipids in a solvent solution (eg. chloroform) 
then to re-suspend them in an aqueous solution (eg. sucrose). Due to the 
amphiphilic properties of the lipids, they will spontaneously self-assemble into a 
structure that is energetically favourable. Vesicle formation can produce 
unilamellar and multilamellar vesicles [Figure 3.1]. As unilamellar vesicles are 
formed of one lipid bilayer, they are more biologically relevant.  
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Figure 3.1 Diagram illustrating a giant multilamellar vesicle, MLV (left) and a giant 
unilamellar vesicle, GUV (right). Vesicle size and membrane thickness are not to scale. 
Pure lipid vesicles can be made, but more importantly, it is possible to make 
vesicles with a specific lipid composition, in order to mimic the lipid composition 
of a particular cell membrane. This also allows the roles of different types of lipid 
to be determined, and their contribution to membrane properties and interactions.  
Using different preparation methods (103), various sizes of vesicles can 
be produced with diameters ranging from ~20 nm to ~100 µm. Unilamellar 
vesicles can be categorised according to their size: Small (20-100 nm), large (100 
nm – 1 µm), and giant (1 – 100 µm). These are referred to as SUV’s, LUV’s and 
GUV’s, respectively. SUV’s have rather different mechanical properties to cell 
membranes, but LUV’s and GUV’s closely resemble cells.  
 
	
3.1.1 Giant Vesicles 
	
Giant vesicles are a widely used membrane system, and are one of the types of 
vesicles used in this experiment. Giant vesicles can either be prepared by the 
swelling technique which results in both uni- and multilamellar vesicles, or the 
electroformation method (104) [Section 3.2.1] which produces mostly unilamellar 
vesicles. This method of vesicle formation is poorly understood, but it is proposed 
that applying an AC current induces mechanical stress on the dried lipid film 
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suspended in an aqueous solution, separating and destabilising the lipid film 
allowing spontaneous formation of vesicles (105).  
It has been shown experimentally that vesicles can adopt various shapes. 
Shape transitions can be induced by a number of factors. A change in 
temperature will induce prolate vesicles to undergo a process called budding 
(106). Changes in osmotic pressure can induce changes to the area-to-volume 
ratio: when the solute concentration is higher than the solution inside the vesicle, 
it deflates (107). Also, using different solutes, at the same osmotic concentration 
inside and outside of the vesicle, can affect the spontaneous curvature causing 
a change in shape (108). It is important to control these factors to ensure the 
stability of the vesicles. Vesicle shape can be predicted from its area, reduced 
volume and spontaneous curvature using the Area-Difference-Elasticity (ADE) 
model, used to model membrane bending elasticity (109). Figure 3.2 shows the 
different shape deformations of a GUV under different osmotic pressure changes.  
	
	
	
Figure 3.2 Shape deformation pathway of a GUV, showing the different shape changes 
produced by an osmotic pressure difference (from (110)). 
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Giant vesicles produced using the electroformation method are mainly 
spherical in shape with a single closed bilayer, which can float freely in aqueous 
solution. GUV’s are especially useful for optical microscopy due to their cell-like 
size and shape (111). They are also used to study mechanical properties of the 
membrane because they exhibit large thermal fluctuations (112). This technique 
will be further described in Chapter 4.  
	
	
3.1.2 Permeability of Bilayer Vesicles 
	
One of the primary functions of biological membranes is to provide a barrier 
between two regions. This barrier is selectively permeable to ions and organic 
molecules and controls the movement of substances in and out of the cell. The 
phospholipid bilayer can greatly modify the permeation of molecules into a cell, 
with the composition of lipids found in the membrane having a vital role in 
permeability. For example, one study has shown membrane permeability to 
antibiotics is dependent on lipid composition, where anionic lipids decrease the 
permeability, whereas neutral lipid vesicles are more permeable (113).  
By analysing phase-contrast images of vesicles, it is possible to determine 
the permeability of the vesicles. This approach exploits the clear difference in 
intensity inside and outside the vesicle, using phase contrast microscopy. This 
allows for a label-free measurement of graphene oxide permeation. To quantify 
this measurement, a permeability coefficient can be calculated. This method has 
been used to study diffusion of antibiotics (113) and will be further discussed in 
Section 3.3.1.  
 The aim of this experiment [Section 3.2.2] is to investigate the permeability 
of bilayer vesicles towards graphene oxide, to determine whether graphene oxide 
can enter vesicles without disruption. A DOPC unilamellar vesicle model has 
been used in this thesis.  
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3.1.3 Self – Quenching Fluorescence Vesicles 
	
During the process of making phospholipid vesicles it is possible to encapsulate 
molecules within the vesicles. Fluorescent tracer molecules can be incorporated 
into the internal fluid phase of the vesicles during formation and changes in 
fluorescence with time provide a marker for permeability.  In this research a 
slightly different approach was used. The vesicles were loaded with a dye at a 
sufficiently high concentration that fluorescence was self-quenched. 
Permeabilisation of the lipid bilayer releases the dye from the vesicle, thereby 
diluting the remaining dye and ‘switching on’ the fluorescence [Figure 3.3]. This 
technique is very sensitive and has been developed in studies on the interactions 
of toxins with membranes (114).   
	
	
	
Figure 3.3 Scheme showing a lipid bilayer vesicle containing self-quenched fluorescent 
dye being permeated by secreted bacterial toxins, resulting in releasing dye and causing 
a fluorescence ‘switch on’. 
	
Previous work has been carried out using these vesicles to investigate the 
interactions of bilayer-targeting toxins, where a fluorescent dye is released from 
the vesicle when in contact with the active toxin (114). In this study, vesicles with 
varying cholesterol concentration were investigated, using carboxyfluorescein as 
the fluorescent dye. The vesicle membrane consisted of a lipid mixture (DPPC, 
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DPPE, CHO, SM) to which was added 10, 12-tricosadiynoic acid (TCDA). TCDA 
is a photo-polymerised fatty acid which creates domains within the vesicle, 
separate to the fluid phospholipid domains containing DPPC and DPPE. TCDA 
gives the vesicles a high stability and makes them more robust.  
In the present research, the effects of graphene oxide on membrane 
permeability were compared with pore-forming toxins, whose effects are well 
characterised. Two toxins were used in this thesis, α-haemolysin, produced by 
the bacterium Staphylococcus aureus and NetB, produced by Clostridium 
perfringens.  The two toxins are similar in structure, however, they differ in their 
pore-forming mechanisms. α-haemolysin forms pores by binding to lipids within 
the membrane containing a phosphocholine head group (115), whereas NetB 
does not bind PC efficiently, and has an affinity towards cholesterol (116). Here, 
the aim is to investigate how graphene oxide interacts with the self-quenching 
fluorescent vesicles, firstly to determine if graphene oxide permeates the 
vesicles, and then the extent to which the vesicles are lysed or permeabilised.	
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3.2 Experimental Methods 
	
	
3.2.1 Electroformation of GUVs 
	
The electroformation method was used to form GUVs, developed by Angelova et 
al (105). Plastic slides coated in Indium tin oxide (ITO), (75 mm x 25 mm), 
(thickness 1 mm, resistivity 60 W/m2, Sigma Aldrich, UK) were used. A Teflon ring 
(thickness 5 mm, outer diameter 30 mm, inner diameter 25 mm) was first washed 
with methanol, then 2 – 3 times with chloroform. A 50 µl Hamilton syringe was 
also cleaned with methanol followed by chloroform, then used to apply uniformly 
10 µl of the DOPC lipid solution in chloroform (10 mg/ml) on the conductive face 
of the ITO slide, inside the circle marked out by the Teflon ring. The ITO plate 
was placed in a vacuum chamber for 2 hours to allow the chloroform to evaporate 
and for a thin uniform lipid film to form. The electroformation chamber was 
constructed from this ITO slide and another ITO slide separated by the Teflon 
ring, the conductive faces being on the inside of the chamber.  Clips were used 
to secure the chamber, applying pressure in order to contain the swelling solution 
[Figure 3.4].  
	
	
	
Figure 3.4 Electroformation chamber, formed from a Teflon ring and two ITO slides, 
sandwiched between two microscope slides. The swelling solution is injected into the 
chamber through a small slit in the Teflon ring. 
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1 ml of swelling solution, consisting of 100 mM or 200 mM sucrose, was injected 
into the chamber. The chamber was incubated at 37°C. Alternating current was 
then driven between the two ITO surfaces. Initially, a 1.2 V peak to peak square 
wave at a frequency of 10 Hz was applied for 1h, followed by a 1.5 V peak to 
peak sinusoidal wave at a frequency of 4 Hz for 1/2 h. The frequency was then 
adjusted to 2 Hz for 15 min, then to 1 Hz for a further 15 min. The electroformation 
chamber was then removed from the incubator and allowed to cool down for 20 
min. The vesicle solution was then transferred to a glass bottle, sealed with 
Parafilm, and stored at 4°C. 
	
	
3.2.2 Imaging of Giant Vesicles and Analysis 
	
Phase contrast microscopy was used to image the vesicles. An optical density 
difference was achieved by using different sugar solutions inside and outside of 
the vesicle. Here, sucrose was used as an internal swelling solution, and glucose 
as the external. The sugars have different molecular weights but were present in 
equal concentrations. These sugars generated the required difference in 
refractive index without altering the osmotic pressure across the membrane. It is 
important to ensure the osmolarities of the internal and external solutions are 
equal to avoid vesicles rupturing due to a change in osmotic pressure. Vesicles 
were observed using an Olympus BX60 microscope set up for phase-contrast, 
with a 40X/0.75 Ph2 objective lens. A Mako G-234C camera was used to capture 
the images. 1 mg/ml graphene oxide solution was prepared in 200 mM glucose 
buffer. The microscope chamber was built using a glass microscope slide and 
cover slip. Both were cleaned first with detergent, and then methanol, then dried 
using lintless tissue paper. Strips of parafilm were used to separate the slide and 
cover slip and were arranged as shown in the diagram [Figure 3.5]. The depth of 
the chamber is controlled by the number of layers of Parafilm used: for these 
experiments only one layer of Parafilm was used. The chamber was constructed 
then placed on a hotplate at ~ 100ºC to seal the chamber. The vesicle suspension 
and graphene oxide solution were mixed before adding to the microscope 
chamber. The vesicle suspension was injected into the chamber, and the four 
The Effects of Graphene Oxide on Red Blood Cells 
 
 
	112	
openings were sealed using molten wax. This was to prevent the otherwise rapid 
evaporation of the vesicle solution. 
	
	
	
Figure 3.5 Vesicle chamber built using a glass microscope slide and cover slip, separated 
by one layer of Parafilm. The vesicle solution is added to the chamber at one of the 
openings and then the chamber is sealed using molten wax. 
 
Images were then taken of suitable sized, unilamellar vesicles every 10 min for 
1h. The images were then analysed using MATLAB [Section 3.3.1].  
	
	
3.2.3 Preparation of Self – Quenching Fluorescent Vesicles 
	
Self-quenching fluorescent vesicles were prepared using a mixture of lipids 
including, 16:0 PC (DPPC), 16:0 PE (DPPE), cholesterol and a cross-linker 
molecule, 10,12-Tricosadiynoic acid (TCDA). The method used was essentially 
that described by Laabei et al (114), producing vesicles of sizes ~ 90 – 110 nm. 
Each component was separately dissolved in 1 ml of chloroform to a 
concentration of 0.1moldm-3. The stock solutions were stored in glass vials at -
20C. Vesicle suspensions were prepared by mixing lipid and fatty acid 
components using 25mol\% TCDA, 53mol\% DPPC, 2mol\% DPPE and 20mol\% 
CHO. This mixture was dried under a nitrogen flow to form a lipid film on the 
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inside of the glass vial. The dried lipid was rehydrated using 5 ml of 5(6)-
carboxyfluorescein (CF) buffer solution, vortexed and heated in a hot water bath 
at 75C for 10 min. Freeze/thaw cycles were carried out by initially immersing the 
lipid-containing vial in liquid nitrogen and then heating the vial back to room 
temperature to homogenise the solution. This was repeated three times. A turbid 
solution was an indication of vesicle formation. Vesicles were then extruded five 
times at 55°C using a Liposofast vesicle extruder (Avestin, USA) through 2 X 0.1 
µM polycarbonate filters under nitrogen pressure. Water was initially run through 
the extruder to ensure removal of ethanol from the previous cleaning procedure. 
The initial opaque vesicle solution became translucent after extrusion. To remove 
any un-encapsulated CF dye, the vesicle solution was purified using Illustrate 
Nap-25 columns. First, the columns were washed with 15 ml of 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer to remove the 
0.15% Kathon CG/ICP biocide, which is present in the column as a preservative. 
(It is crucial that the biocide is removed to prevent false readings later on.) Then 
2.5 ml of vesicle solution was added to each column and allowed to load. 1 ml of 
HEPES buffer was added and left to drain. After this, a further 2.5 ml of HEPES 
buffer was added and the resultant pure vesicle was collected and stored at 4°C 
for 2h. The TCDA molecules present in the lipid vesicles were then cross-linked 
and photo polymerised using a CL1000 Ultraviolet cross linker (Hamamatsu, 
Japan) for 6s [Figure 3.6].   
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Figure 3.6 Scheme to show the conformational change of 10,12-Tricosadiynoic acid 
(TCDA) molecules, one of component of the lipid vesicles, after exposure to UV light. 
Cross-linking of these molecules gives the vesicles high stability. 
 
3.2.4 Fluorescence Intensity Assay 
	
The fluorescence intensity was measured using a fluorescence plater reader 
(Tecan Pro Infinite 200), at excitation and emission wavelengths of 485 nm and 
520 nm respectively. For graphene oxide measurements, 50 μl of vesicle solution 
was mixed with 50 μl of graphene oxide suspended in HEPES (Sigma Aldrich, 
UK) buffer, in a 96-well plate. The graphene oxide concentration ranged from 
0.01 mg/ml to 0.1 mg/ml. The well plate was incubated in the fluorimeter at 37°C 
for 1h. Measurements were taken over 30 kinetic cycles with 2 min intervals. Each 
experiment was performed in duplicate. Positive (0.1% Triton X-100, Sigma 
Aldrich, UK) and negative (HEPES buffer) controls were used to normalise 
fluorescence. The same method was used for initial experiments testing the 
following pore-forming toxins: α-haemolysin (0.5 mg/ml, List Biological 
Laboratories Inc, USA) and	 NetB (0.45 mg/ml) which was isolated from 
C.perfringens, cloned and purified before use by another group using the 
methodology detailed in (116).  	  
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3.3 Results and Discussion 
	
	
This section includes all results for graphene oxide permeability experiments 
carried out using giant vesicles and self-quenching fluorescent vesicles, including 
a comparative study with pore-forming toxins.  
	
	
3.3.1 Permeability of Giant Vesicles 
	
To calculate the permeability coefficient, first, the normalised fluorescence 
intensity differences between the inside and the outside of the vesicle at t = 0 
(∆I1) and at t = tf  (∆I2) were calculated using the following equations: 
 
	
where I1 and I2 correspond to the average internal intensities measured around 
the centre of the vesicles at times t = 0 and t = tf. Iout is the intensity outside of the 
vesicle. The relative intensities ∆𝐼], before the addition of graphene oxide, and ∆𝐼Q, a time point after graphene incubation, can be calculated (using MATLAB). 
The following equation calculates the permeability coefficient,  
	
 −𝑃 = 𝑅3𝑡 ln ∆𝐼Q − ∆𝐼] + 1   (3.3) 
where P is the permeability coefficient, R is the vesicle radius and t is the time 
taken from initial vesicle detection to the first point of detection after GO 
treatment.  
Figure 3.7 shows an example of a giant vesicle (~ 8.5 µm) in a glucose 
external swelling solution without treatment with graphene oxide, monitored over 
 ∆𝐼] = 	 𝐼jkl − 𝐼]𝐼jkl ; (𝑡 = 0) 
 
 
(3.1) 
 ∆𝐼Q = 	 𝐼jkl − 𝐼Q𝐼jkl ; (𝑡 = 𝑡n)  (3.2) 
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1h. The WU fluorescence filter cube was used as it gave the optimum contrast 
between inside and outside the vesicle. There are no changes in intensities or 
differences in contrast observed over 1h. Figure 3.8 shows a series of images 
taken of a giant vesicle, exposed to 1 mg/ml graphene oxide in glucose showing 
loss of contrast after 10 min exposure with complete loss of contrast observed 
after 60 min. For all measurements, a 10 minute period was given to find a 
suitable vesicle.  
 
 
 
Figure 3.7 Snapshots of a giant vesicle viewed using phase-contrast microscopy (40X/0.75 
Ph2 objective), taken every 10 min over 1 h. (left to right, 10 min to 60 min).  
	
	
	
Figure 3.8 Snapshots of a giant vesicle, treated with 1 mg/ml graphene oxide suspended 
in a 200 mM glucose solution. Images were taken every 10 min for 1 h (left to right).  
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Using equations 3.1 – 3.3, the permeability of the giant vesicles can be 
calculated. Figure 3.9 shows an average of the permeability coefficients obtained 
from the samples used. After 10 minutes of exposure to graphene oxide the 
average permeability coefficient was 0.72 ± 0.05 x 10-3 cm s-1 increasing to 0.99 
± 0.05 x 10-3 cm s-1 after 1h (n=5). This is an obvious increase in permeability 
compared to the control vesicles where an average of 0.16 ± 0.02 x 10-3 cm s-1 
was obtained [Figure 3.10]. The greatest increase in permeability is observed at 
t=10 min, suggesting GO permeation of the vesicles occurs initially. The 
permeability coefficient stays reasonably constant throughout the experiment, 
with only a slow increase to 0.27 x 10-3 cm s-1 observed over 1h, which could 
mean the vesicle becomes saturated by GO. It is possible that further GO from 
the solution permeates the vesicle after the initial saturation, however it does not 
seem to have a significant effect.   
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Figure 3.9 The average calculated permeability coefficients over 1 h for DOPC vesicles 
treated with 1 mg/ml graphene oxide suspended in 200 mM glucose (n=5).  
 
 
 
Figure 3.10 A comparison of the averaged calculated permeability coefficients for DOPC 
vesicles treated with 1 mg/ml graphene oxide in 200 mM glucose (black), with control 
vesicles treated with 200 mM glucose (red). 
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Figure 3.11 shows the proposed interactions of GO with a vesicle. Possible 
permeation could occur from “edge on” GO due to its smaller width compared to 
“side on” GO, forming holes within the bilayer. It is possible “side on” GO is 
interacting with head groups of vesicles, saturating but not entering the vesicle.  
 
	
Figure 3.11 the proposed interaction of GO with giant vesicles. The expected initial 
interaction is shown at 0 min (left) and after 10 min (right). Due to the size of the GO, “edge 
on” GO is predicted to permeate the vesicle forming holes allowing GO to enter the vesicle. 
GO permeation of the vesicle occurs initially with very little change in permeation over the 
1h time course.  
As can be shown from images of vesicles treated with GO [Figure 3.8] it 
appears initial permeation is likely to occur before 10 minutes. However, due to 
the method used for this experiment, measurements could not be accurately 
recorded before 10 minutes. To overcome this, further experiments were carried 
out using self-quenching fluorescence vesicles, which allows fluorescence 
intensity measurements to be recorded using a fluorimeter. Although the self-
quenching vesicles are smaller than the giant vesicles (~100 nm) and are not 
representative of the size of a cell, it is useful for investigating the GO-lipid 
interactions. 	  
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3.3.2 Permeability of Self – Quenching Vesicles 
	
Initial experiments were carried out investigating the interactions of known 
pore-forming toxins with the vesicles. All experiments were performed in 
duplicate. The samples were incubated at 37ºC for 1h and the fluorescence 
response was measured. An incubation temperature of 37ºC was chosen to 
provide biologically relevant experimental conditions. Figure 3.12 shows the 
fluorescence response of α-haemolysin and NetB. Both positive (Triton X-100) 
and negative (HEPES buffer) controls were used in fluorescence normalisation. 
Normalised fluorescence was calculated using the equation,  
	
 (𝐹l − 𝐹-) (𝐹o − 𝐹-) 
 
 
(3.4) 
where Ft is the average fluorescence value at a specific time point, F0 is the 
minimum fluorescence and Fm is the maximum fluorescence shown in that 
particular experiment. The loss of fluorescein from the vesicles can be calculated 
as a percentage using the maximum release of dye with the addition of 0.01% 
Triton X-100.  
	
	
	
Figure 3.12 The average fluorescence response of the vesicles to two membrane-targeting 
toxins: α-haemolysin (black) and NetB (red), over 1h. Fluorescence values were measured 
and normalised. 
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NetB gave the greatest response with ~ 8% fluorescein leakage. This experiment 
was repeated over a range of NetB concentrations [Figure 3.13]. There is little 
fluorescence response at the lower concentrations of NetB, with only 0.45 mg/ml 
showing ~ 14% fluorescein leakage. 
 
Figure 3.13 Fluorescence response of the vesicles to the toxin NetB, in the concentration 
range 2 x 10-3 mg/ml – 0.45 mg/ml. Fluorescence values were measured over 1h and the 
data was normalised.   
Although there is not a strong fluorescence response from the NetB, it is useful 
to use as a comparison for graphene oxide experiments using similar 
concentrations. What is clear from these results is that as the concentration of 
NetB increases, the fluorescence response increases, with a significant increase 
at the higher concentrations [Figure 3.14].  
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Figure 3.14 The fluorescence response as a function of NetB concentration over 1h.  
Figure 3.15 shows the fluorescence response using a range of graphene oxide 
concentrations, in HEPES buffer, incubated for 1h at 37°C. This is also expressed 
as a function of graphene oxide concentration [Figure 3.16].  
An increase in fluorescence is observed over time, with a significant 
increase at the higher concentrations of graphene oxide. For 0.1 mg/ml graphene 
oxide, there is a brief lag period of ~ 2 min, which probably reflects the time period 
required for graphene oxide to specifically adsorb to the membrane and to begin 
permeating the bilayer. This is followed by a sharp increase in fluorescence 
intensity over the next 20 min, which appears to plateau after ~ 30 min, 
suggesting no further fluorescein leakage from the vesicle and this steady state 
level is reduced as smaller concentrations of graphene oxide are used. 0.1 mg/ml 
graphene oxide causes ~ 35% fluorescein leakage which shows GO does not 
cause complete lysis of the vesicles, suggesting a specific mechanism of 
interaction. A plateau in fluorescence intensity is unlikely to be caused through 
all of the graphene diffusing into the vesicle. One possible suggestion is the GO 
interacts with only one component of the vesicle which then saturates. Another 
possibility could be that the vesicle bilayer ‘re-seals’ itself, blocking further 
fluorescein leakage. This has previously been reported (117), finding GO to 
permeate DOPC vesicles which successively led to reduced membrane tension, 
driving the pores to close (118) in a self-healing manner.  
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Figure 3.15 Fluorescence response of the vesicles to the graphene oxide, over the 
concentration range 0.01 - 0.1 mg/ml. Fluorescence values were measured over 1h and the 
data was normalised using the positive and negative controls. 
 
 
Figure 3.16 The fluorescence response as a function of graphene oxide concentration (t = 
1h). 
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To determine vesicle permeability the same principle using equations 3.1 
– 3.3 can be applied for this experiment, assuming 𝐼jkl is the maximum 
fluorescence intensity observed, ∆𝐼] is calculated from positive and negative 
controls, and ∆𝐼Q is calculated from vesicle treatment with graphene oxide at a 
specific time point. Figure 3.17 shows the average permeability coefficients (n=6) 
calculated for self-quenching vesicles treated with graphene oxide over a 
concentration range. As the graphene oxide concentration increases, the 
permeability increases. The permeability coefficient increases from 0.12 ± 0.005 
x 10-6 cm s-1 to 1.65 ± 0.12 x 10-6 cm s-1.  
 
 
 
Figure 3.17 The average calculated permeability coefficients over 1 h for self-quenching 
fluorescence vesicles containing fluorescein, treated with graphene oxide suspended in 
HEPES buffer, over a concentration range from 0.01 – 0.1 mg/ml (n=6).  
One observation that can be drawn on is the difference in permeability between 
the two preparations of vesicles. The highest permeability calculated for GUVs 
was 0.99 ± 0.05 x 10-3 cm s-1, with a significant decrease to 1.65 ± 0.12 x 10-6 cm 
s-1 calculated at the highest concentration of GO used to treat self-quenching 
vesicles. From this it can be said DOPC vesicles are more permeable than the 
self-quenching vesicles. We hypothesise that the difference in membrane 
permeability is due the properties of the vesicles: their size and lipid composition. 
The average size of DOPC vesicles was ~ 8 µm, whereas the self-quenching 
vesicles are significantly smaller at ~ 0.1 µm. The self-quenching vesicles also 
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have a more complex lipid composition, including the TCDA linker molecule which 
decreases membrane fluidity. The DOPC vesicles are simpler in structure, but 
the fatty acid tails of the lipids are unsaturated, which could affect membrane 
fluidity (119). Figure 3.18 shows the average permeability coefficients calculated 
for vesicles treated with 0.1 mg/ml GO and its control, over 1h.  
 
Figure 3.18 The average calculated permeability coefficients over 1h for self-quenching 
vesicles treated with 0.1 mg/ml GO (black) and vesicles treated with HEPES buffer (red).  
	
There is a slow increase in permeability over the first ½ h from 0.7 x 10-6 cm s-1 
to ~ 1.55 x 10-6 cm s-1, where the curve plateaus. The addition of TCDA molecules 
and cholesterol decreases the permeability of the vesicle, which could decrease 
the rate of GO permeation. The plateau suggests that either, like the giant 
vesicles, the GO saturates the vesicle preventing further permeation. Or it is 
possible that the GO is interacting specifically with one of the phospholipids in 
the self-quenching vesicles, and therefore only permeating the vesicles in specific 
locations. From the results achieved using DOPC vesicles, which only have one 
lipid component, it can be suggested that GO permeates vesicles by interacting 
with the PC head groups of the lipids, forming holes within the bilayer. Figure 3.19 
gives the proposed mechanism of interaction of GO with the vesicles.  
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Figure 3.19 The proposed interactions of GO with self-quenching fluorescence vesicles. 
The addition of molecules which decrease permeability is likely to affect how much GO 
can permeate the membrane. It is possible GO is forming holes within PC regions of the 
vesicle.  
By comparing the graphene oxide results with the results achieved using 
pore-forming toxins, it is clear graphene oxide creates greater permeability in the 
vesicles, shown by the greater fluorescence response. It is possible GO is also 
forming “pore-like” structures within the bilayer, similar to the toxins. The greater 
increase in fluorescence suggests GO either forms larger pores, compared to 
NetB, or similar sized pores with more attachment sites on the vesicle. Lipid 
vesicles have previously been used to determine NetB has an affinity towards 
cholesterol but not PC, interacting directly with cholesterol in the absence of other 
lipids (116). It is unclear from these results whether GO has any other interactions 
with the other lipid components of the vesicles. It could be possible that GO 
specifically interacts with PC head groups, with a greater fluorescence response 
observed with GO than NetB, with a greater concentration of DPPC and 
cholesterol present in the vesicle, 53mol\% and 20mol\% respectively. However, 
a low fluorescence response was observed with α-haemolysin, a toxin with a 
specific PC binding pocket (116). Further research investigating individual lipid-
GO interactions would be required to determine the exact mechanism in which 
the GO is acting.  
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3.4 Conclusions 
	
	
From experimentally determining the permeability of GO towards different 
compositions of vesicles, it can be concluded that GO permeates vesicles, rather 
than causing complete lysis of the vesicles. This was confirmed using two 
different experiments. Firstly, by analysing changes in the optical density of a 
series of images of giant DOPC vesicles treated with graphene oxide. The 
difference in contrast inside and outside the vesicle is caused by using two 
different solutions with containing sugars of different molecular weights but equal 
concentrations. The addition of graphene oxide showed an obvious change in 
contrast, suggesting the vesicle had been permeated causing an exchange of 
internal sucrose solution and the external glucose solution, resulting in a loss of 
contrast. The second experiment used self-quenching fluorescence vesicles to 
measure the permeability of graphene oxide, by measuring the change in 
fluorescence intensity over a period of time. Permeability is determined by the 
leakage of the fluorescein from the vesicle. Initially the fluorescence intensity is 
low, where the fluorescein inside the vesicle is quenched. As the vesicle is 
permeated and the fluorescein leaks out, the intensity increases. The results from 
this experiment showed an increase in fluorescence over time, as well as an 
increase at higher concentrations of graphene oxide. Therefore, there is an 
overall increase in permeability. From both experiments it is proposed that GO 
may permeate vesicles by interacting with PC lipids “edge-on”, forming holes in 
the bilayer, with “side-on” GO interacting with head groups saturating the outer 
lipid layer.  
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Chapter 4 The Effects of Graphene Oxide on Red Blood 
Cells 
	
	
4.1 Introduction 
	
	
In this chapter I will discuss experiments investigating the interactions of 
graphene oxide and red blood cells. Red blood cells (RBC) have a simple 
structure meaning we can look specifically at the interactions at the membrane, 
which is very similar to those of most mammalian cells. As the most abundant 
cell within the blood, it would be unavoidable to administer graphene-based 
materials into the blood without contact with RBCs. Any interactions will help 
determine the bioavailability of graphene and the kinetics of its distribution in 
tissues, relevant both to biomedical applications and safety. Determining how 
graphene oxide interacts with RBCs is therefore paramount in assessing its 
biological safety. The aim of this experiment is to determine if and how graphene 
oxide interacts with red blood cells. Analysing the fluctuations of the RBC 
membrane allows us to detect any changes in the mechanical properties of the 
cell membrane caused by graphene oxide. Absorbance measurements allow us 
establish whether graphene oxide changes the shape of the RBC, or produces 
haemoglobin leakages. We will also use Raman spectroscopy to determine 
whether graphene oxide is taken up by RBCs and where it accumulates in or on 
the cell.  
	
	
4.1.1 Structure and Properties of Red Blood Cells 
	
The red blood cell is the simplest of all biological cells, with no nucleus and no 
internal organelles. A mature cell is almost exclusively full of haemoglobin, the 
oxygen-binding protein, which allows for transport of oxygen throughout the body. 
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RBCs typically have a diameter of 5 – 8 μm with a biconcave disc shape. The 
biconcave disc allows for an increased surface area-to-volume ratio, improving 
oxygen transfer across the membrane, and also enables the cell to undergo 
deformations so they can pass through capillaries half the size of the cell. This 
biconcave shape is determined by the properties of the membrane. The structure 
of a mature red blood cell makes them an ideal candidate to use as a model 
membrane system, as well as being easily available. The red blood cell 
membrane mass consists of ~52% proteins, ~40% lipids and 8% carbohydrates. 
The membrane is approximately 20 nm thick and consists of a quasi-fluid lipid 
bilayer, with proteins embedded. The membrane proteins are anchored to a 
network of proteins on the cytosolic side of the membrane. This is known as the 
membrane cytoskeleton. The cytoskeleton is formed from various structural 
proteins; spectrin, ankyrin, protein 4.1, actin and several other proteins [Figure 
4.1].   
	
	
	
Figure 4.1 The structure of the RBC membrane (Tse and Lux, 1999). Showing the lipid 
bilayer with trans-membrane proteins embedded, and the primary structural protein 
spectrin that forms part of the cytoskeleton. From (120). 
This network provides support to the membrane increasing the cells overall 
mechanical strength, in order to withstand regular deformations. The membrane 
is robust in order to withstand shear stresses.  
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Shape changes of RBCs are of great interest, particularly because they 
are lacking any internal organelles, and the biconcave shape of red blood cells 
being determined solely by the membrane mechanics., the shape transitions of 
the cell are due to changes in the cell membrane, either structure or composition 
of the lipid bilayer or underlying cytoskeleton. Shape transitions are often 
observed when the cell is in a pathological state, therefore the mechanical 
changes of the membrane is of great importance to understanding the structural 
significance of the pathological changes to the cell.   
 
	
4.1.2 Membrane Elasticity 
	
The primary role of the red blood cell is to transport oxygen from the lungs to the 
rest of the body. There are many diseases which show reduced performance of 
RBCs due to deformabilities such as sickle cell disease. Sickle cell disease 
results from a defect in the haemoglobin structure caused by substituting one 
amino acid causing a change in cell shape (crescent like). This change in shape 
can cause blocking of blood vessels resulting in an inefficient oxygen supply to 
surrounding tissues (121). As described in Chapter 1, the RBC is one of two 
typical systems used to demonstrate membrane elasticity. Studies have shown 
the lipid bilayer, membrane-associated proteins, as well as the cytoskeletal 
network contribute to the stability and deformability of the red blood cell (122). 
Research has largely been focused towards the most abundant cytoskeletal 
protein, spectrin. Several experimental techniques have been applied to 
characterise the deformations of RBCs including micropipette aspiration (123) 
and optical tweezers (124). These methods, however, only provide information 
about the membrane mechanics in static conditions.  
RBC thermal fluctuations, ‘flickering’, provide comprehensive 
characterisation of membrane mechanics and have been studied extensively to 
better understand the relationship between the lipid bilayer and the cytoskeleton 
(125). RBCs flicker due to the Brownian motion of their thin membrane (126), 
resulting in fluctuations.  
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The RBC membrane can be described as a 2D surface, embedded in 3D 
space. The mean curvature of a membrane can be defined as, 
 
	
 𝐻 ≡ (1 𝑅] +	1 𝑅Q)2  
 
 
 
(4.1) 
and the Gaussian curvature as,  
 
 𝐾 ≡ 1(𝑅]𝑅Q) 
 
 
 
(4.2) 
where the local curvature of the membrane, C, is C = 1/R, and R is the radius of 
the curvature characterised by two principal radii [Figure 4.2].  
	
	
 
Figure 4.2 Radii of curvature R1 and R2, associated with one point of the surface. 
 
The energy required to bend a bilayer increases with curvature. The simplest 
form for this energy density, f0, is defined as,  
 
 𝑓- ≡ 𝑘u2 (2𝐻)Q + 𝑘v𝐾 
 
 
(4.3) 
where kb is the bending modulus and kG is the Gaussian bending modulus, 
derived from the classical curvature model for symmetrical membranes (127) 
(112). Giant vesicles, and many biological membranes, have a bending rigidity of 
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the order ~10 kT (128) (129), resulting in visible thermal fluctuations at room 
temperature. By analysing shape fluctuations, it is possible to determine the 
bending modulus.  
An investigation into the mechanical properties of RBC membranes, 
treated with and without graphene oxide, will give an insight into how graphene 
interacts with cell membranes.  
 
	
4.1.3 Thermal Fluctuation Spectroscopy 
	
Thermal fluctuation spectroscopy is a recent technique designed to analyse giant 
non-spherical vesicles (130), developed from a simpler technique, which only 
analyses quasi-spherical vesicles. This technique has been further developed in 
order to analyse shape fluctuations of red blood cells (131). Phase-contrast 
microscopy is used to capture a time sequence of images of the fluctuating red 
blood cells. By using image analysis software, it is possible to obtain a 2-
dimensional contour map of the membrane [Figure 4.3].  
	
	
	
Figure 4.3 Phase contrast image of a red blood cell, showing a traced contour of the cell 
membrane. The polar coordinates (r,q) are also shown. 
The two-dimensional contours are fitted using a Fourier series, using polar 
coordinates (r,q), with the origin at the centre of the area [Figure 4.3].  
 
r(q) 
q 
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 𝑟 𝜃, 𝑡 = 𝑟-(𝑡)	 1 + 𝑎R(𝑡)R 𝑐𝑜𝑠 𝑛𝜃 + 𝑏R(𝑡)𝑠𝑖𝑛 𝑛𝜃R  
 
 
 
(4.4) 
The time dependence of the resulting amplitudes, 𝑎R(𝑡) and 𝑏R(𝑡), encode all the 
necessary information about the shape fluctuations. 𝑎R and 𝑏R differ by		𝜋 4 
rotation. The values extracted by fitting equation 4.4 to a set of experimental 
contours, describes the mean contour shape [Figure 4.4].  
 
 
Figure 4.4 shape deformations corresponding to the first 5 Fourier modes of Equation 4.4. 
The contour shape fluctuations around the mean shape are quantified using the 
mean square values of the amplitudes for each mode,  
 
 𝛿RQ = 𝑎RQ − 𝑎R Q + 𝑏RQ − 𝑏R Q   
  (4.5) 
the same analysis used for fluctuation vesicles (132). A typical fluctuation 
spectrum for a normal red blood cell is shown in Figure 4.5. As the mode number, 
n, increases there is a significant drop in the mean square fluctuations, as 
expected.  
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Figure 4.5 A typical fluctuation spectrum of a normal red blood cell, obtained from the 
Fourier analysis of the RBC contours. From (133). 
The lower order modes encode the essential information regarding membrane 
elasticity. Modes up to n » 18 can be recorded reliably using this method.  
The fluctuations of the amplitudes in the Fourier series enables extraction 
of the shear (µ) and bending (𝜅) elastic moduli, and the membrane tension (𝜎).  
 
 𝐶RQ = 12𝜋 1𝜅 𝜎Q − 𝛾 𝜎 + 𝑛Q − 𝜎Q − 𝛾 \]/Q − 𝜎 + 𝑛Q + 𝜎Q − 𝛾 \]/Q    
(4.6) 
where 𝜅 º k/(kbT), 𝜎 is a dimensionless membrane tension. 𝛾 and n are also 
dimensionless quantities. For lipid bilayers without a cytoskeleton, Equation 4.6 
can be reduced to  
 
 𝐶RQ = 12𝜋 1𝜅𝜎 1𝑛 − 2𝜎 + 𝑛Q \]/Q   
  (4.7) 
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the equation for analysing contour fluctuations in vesicles (134). For red blood 
cells, equation 4.6 can be used to extract values for the bending modulus and the 
membrane surface tension, using non-linear regression analysis.  
This method will be used to characterise the mechanical properties of the 
red blood cell membrane, and how graphene oxide affects these properties. 
However, there is one other important component of the red blood cell to 
consider: the oxygen-carrying protein, haemoglobin.  
 
	
4.1.4 Haemoglobin Absorbance 
	
Haemoglobin, the oxygen carrier of the red blood cell, consists of a haem group, 
containing iron, coordinated to four nitrogen molecules, forming a porphyrin ring. 
It facilitates oxygen transport by binding to oxygen molecules. Human RBCs 
contain high concentrations of haemoglobin (0.4 mg/ml). Spectroscopic 
techniques have been used to study interactions of molecules with 
electromagnetic radiation. UV-visible absorption spectroscopy has shown that 
haemoglobin exhibits strong absorption above 320 nm (135). The porphyrin ring 
exhibits strong absorption around 400 nm, known as the Soret region. This region 
is characteristic of porphyrin proteins. Different variants of haemoglobin, such as 
oxy- and ferri- haemoglobin, exhibit different maximum absorbance. According to 
the Beer-Lambert law, the specific absorption coefficients of an absorbing 
material can be defined by the equation 
	
 𝐴 = 𝑙𝑜𝑔]- 	𝐼-𝐼 = 	𝛼	𝑐𝑙 
 
 
 
(4.8) 
where I0 is the intensity of incidence light, I is the intensity of transmitted light, l is 
the path length, c is the concentration of absorbing material and 𝛼 is the 
absorption coefficient. With regards to red blood cells, the concentration here is 
that of haemoglobin and I0 is the intensity of the light surrounding the cell. With 
red blood cells, it is possible to obtain an absorbance intensity profile, by plotting 
radial distance of the cell versus absorbance. This gives a profile, which traces 
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the shape of the cell, which in turn can be used to analyse changes in red blood 
cell shape. As a general rule, the higher the absorbance intensity, the more 
haemoglobin there is, and therefore the thickness of the cell would be bigger. 
Figure 4.6 shows an image of a human red blood cell using a 420 nm light. This 
technique can be used to determine the shape of the RBC (perpendicular to the 
light path) and, by integration, the total haemoglobin content of the cell.  
	
	
	
Figure 4.6 Image of a red blood cell viewed using bright-field microscopy, illuminated 
using a 420 nm light source. 
	
	
4.1.5 Raman Spectroscopy of Red Blood Cells 
	
To determine the location of graphene oxide within the red blood cell, Raman 
spectroscopy is used. Raman spectroscopy is a vibrational spectroscopy 
technique used for qualitative and quantitative analysis, by providing a unique 
chemical molecular fingerprint. It can be used to identify samples, and quantify 
the molecular components in the sample through their vibrational energy states. 
It does this by looking at particular molecule vibrations. Vibrational energy levels 
are different for every molecule. Light from a monochromatic light source (a laser) 
is shone on the sample. The majority of the scattered light remains unchanged, 
known as Raleigh scattering. A small amount of the scattered light shifts in energy 
from the laser frequency because of the interactions between the incident 
electromagnetic waves and the molecular vibrational energy levels in the sample. 
A Raman spectrum measures the intensity of shifted light versus frequency. Band 
positions within the spectrum are at frequencies corresponding to energy levels 
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of different functional group vibrations. The band areas are proportional to the 
concentration of molecules in the sample. The Raman spectrum of graphene is 
commonly used as a method of characterising graphene and its derivatives, and 
the spectra are well known (136).  A Raman spectrum of graphene oxide [Figure 
4.7] shows its main characteristic peaks at ~ 1580 cm-1 (the ‘G peak’) and at ~ 
1350 cm-1 (the ‘D peak’).  
	
	
	
Figure 4.7 Raman spectra of graphene oxide, showing the G peak at 1580 cm-1 and the D 
peak at 1350 cm-1. 
Raman spectroscopy has also been widely used to study the molecular 
composition of single cells, including red blood cells. Both oxygenated and 
deoxygenated cells have been studied using Raman (137). Figure 4.8 gives an 
example of the Raman spectrum of an oxygenated RBC recorded using an 
excitation wavelength of 532 nm. There are several spectral regions reported, 
1200 – 1250 cm-1, 1355 – 1376 cm-1 and 1500 – 1650 cm-1, to be characteristic 
of an oxygenated RBC (138) (137). 
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Figure 4.8 Raman spectrum of an oxygenated RBC recorded at 532 nm excitation 
wavelength 
 
 
4.1.6 Previous Work 
	
There have been initial studies researching interactions of GO and RBCs. Liao 
K-H et al. investigated the haemolytic activity of GO in human erythrocytes by 
measuring the haemoglobin present in the RBC suspension (60). Several 
graphene oxide suspensions (0.05 mg/ml) were used in this experiment, varying 
the sonication intensity and time to produce different sized flakes. They 
concluded smaller GO flakes, produced by probe sonication for 30 min, showed 
a higher haemolytic activity, compared to bigger flakes produced by shorter probe 
sonication and longer bath sonication. This suggested that membrane disruption 
is due to electrostatic attractions between the negatively charged graphene 
oxide, and positively charged PC lipids present on the outer membrane of the red 
blood cell.  
In contrast, Zhang X. et al. reported good biocompatibility of graphene 
oxide with red blood cells (139). At GO concentrations of 10 µg/ml GO flakes 
adhered to the surface of the cells, but had little effect on morphology or 
membrane integrity. However, at higher concentrations, 80 µg/ml, ghost cells 
were observed. Ghost cells are RBCs which are visibly intact but have lost their 
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haemoglobin content, suggesting damage to the cell membrane causing the 
contents of the cell to leak out.  
The GO preparations used in the following experiments differ from those 
previously used. A higher concentration of GO (1 mg/ml) is used throughout, 
using centrifugation to remove any aggregated GO and to produce a preparation 
with a uniform flake size distribution of ~ 500 nm.  
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4.2 Experimental Methods 
	
	
4.2.1 Preparation of Graphene Oxide Suspension 
	
In the following experiments, 1 mg/ml graphene oxide solutions, in phosphate 
buffer solution (PBS) with 1% bovine serum albumin (BSA, Sigma-Aldrich, UK), 
were used. The graphene oxide was sonicated in the PBS buffer for 1h, and 
centrifuged at 10,000 rpm for 10 min. The supernatant was collected, and the 
pellet discarded. 
	
	
4.2.2 Microscope Chamber Preparation 
	
The RBC chamber was constructed using standard glass microscope slides (75 
mm x 25 mm x 1 mm), Parafilm and a thin glass cover slip (22 mm x 22 mm). All 
microscope slides and glass cover slips were cleaned using ethanol. Thin strips 
of Parafilm were used to create the chamber, by acting as a spacer between the 
slide and the coverslip. The Parafilm was placed on opposite sides of the 
microscope slide to form an open-sided chamber. The chamber was bonded 
together by applying heat from a hot plate in order to secure the slide and 
coverslip to the Parafilm. This formed a chamber ~ 1 mm in depth [Figure 4.9].  
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Figure 4.9 RBC open-sided chamber, prepared using a glass microscope slide and cover 
slip, separated by a single layer of Parafilm, sealed by applying heat. The RBC solution is 
introduced to the chamber by pipetting underneath the cover slip. The graphene oxide 
solution is added via buffer exchange through the chamber. 
The open-sided chamber was used to allow for buffer exchange during the 
experiments. Excess solution was dropped onto the microscope slide at one end 
of the chamber, allowing the buffer to be pulled through the chamber with the aid 
of filter paper placed on the opposite side.  
 
	
4.2.3 Blood Sample Preparation 
	
A PBS buffer was used throughout these experiments, with a pH of 7.4 to which 
was added 1 mg/ml BSA (Sigma-Aldrich, UK). BSA was used to maintain the 
shape of the red blood cells, once the cells had been added to the chamber. It 
counteracts what is known as the “glass effect” which causes cells to change 
shape once in contact with the microscope slide (140). Fresh human blood 
samples were collected using a pin-prick lancet (Accu-Chek, Softclix Plus, Roche 
Ltd) immediately before each experiment and suspended in 1 ml of PBS 1% BSA 
buffer. Approximately 2 – 5 μl of blood was used. 20 μl of the suspended cells 
were placed in the microscope chamber using a Gilson pipette. By holding the 
pipette tip downwards onto the microscope slide, next to the glass cover slip, the 
cells could be injected into the chamber. The cells were then left for 5 – 10 min 
to settle. The difference in density between the red blood cell and the buffer, 
allows the red blood cells to stabilise at the bottom of the chamber, allowing 
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membrane fluctuations to be observed. 200 μl of graphene oxide was added to 
the chamber via buffer exchange. During buffer exchange it was found to be 
important to keep a slow, constant supply of the solution to the chamber, to avoid 
drying out. 
	
	
4.2.4 Fluctuation Spectroscopy 
	
A fast-video phase-contrast microscope (Leica DMLFS) was used to view 
fluctuating red blood cells, using a 530 nm light source (Thorlabs, Mounted High-
Power LED M530L2), which allowed membrane flickering to be observed. The 
microscope was equipped with a 63X PL Fluotar phase-contrast objective. Video 
sequences of the fluctuating red blood cells were taken using a Q-Imaging 
camera at a typical frame rate of 7 fps. Initial experiments were carried out to 
determine the time course required for the following experiments. After first taking 
acquisitions every 5 min for 1h, it was determined that during the first 5 minutes 
there were significant changes to the RBC radius. From this it was decided that 
acquisitions would be taken over a period of 1/2h, taking one reading after 1 min, 
then increasing to 5 min, then 10 min, until 30 min. Once a series of contours 
(~1500) was acquired, they were then analysed to quantify the membrane 
fluctuations.  
The fluctuation microscopy was repeated with GO/RBC suspensions over 
a longer time course, and at different temperatures. ~ 2 – 5 µl of blood was added 
to 500 µl of graphene oxide solution and incubated over a range of time periods 
(1/2h, 1h, 2h) and a range of temperatures (4°C, room temperature, 37°C). All 
cells were washed using PBS to remove excess graphene oxide before 
fluctuation measurements.  
	
	
4.2.5 Absorbance Measurements 
	
For absorbance experiments, videos of cells were taken using bright-field 
microscopy, using a 420 nm light source (Thorlabs Mounted High-Power LED 
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M420L2). 20 µl of RBC/PBS solution was added to the microscope chamber, and 
the video was taken. For graphene oxide measurements, 20 µl of RBC was added 
to 200 µl of the graphene oxide suspension, and left for ½ h at room temperature. 
Videos were then taken of the graphene oxide treated cells, in the same way as 
before. ImageJ analysis was used to calculate the absorbance at different points 
across the cell. The average absorbance intensity was recorded and a curve 
fitting tool (MATLAB) was used to reconstruct the cell profile and calculated the 
integrated area of the curves.  
	
	
4.2.6 Raman Spectroscopy 
	
4.2.6.1 Slide Preparation 
	
In order to hold the red blood cells in place on the microscope slide, the slides 
were first coated in poly-L-lysine. The poly-L-lysine was diluted in deionised water 
(1:10) prior to slide coating. Slides were first cleaned with ethanol. The clean 
slides were placed into a slide rack, then into the poly-L-lysine solution for 5 min. 
The slides were then drained and dried at room temperature overnight. When 
dry, nail varnish was used to create a chamber on the slide, in order to avoid the 
cells drying out. 20 μl of RBC/graphene oxide solution was then dropped onto the 
slide, and a cover slip was placed over the top. The cells were then left for 15 min 
to allow sufficient time to adhere to the slide.  
	
	
4.2.6.2 Raman Measurements 
	
Raman spectra of RBCs were acquired using WITec Alpha300 R Raman imaging 
system. A 532 nm laser was used with a 50X objective. The laser power on the 
sample was 2.3 mW. Raman spectra were collected from 0 cm-1 to 3600 cm-1 with 
an integration time of 0.1 s. Raman maps were constructed using WITec Project 
4.1 software with Shape plus graph background subtraction. 
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4.3 Results and Discussion  
	
	
This section includes all results from the fluctuation spectroscopy of red blood 
cells, with and without exposure to graphene oxide, including calculations of the 
bending modulus. It also includes the effects of graphene oxide exposure over 
longer time periods, at room temperature and 37°C. Results showing absorbance 
plots of the cross-section of the RBC will also be described. Finally, the results 
from the Raman spectroscopy study locating graphene oxide within the cell will 
be discussed.  
	
	
4.3.1 Fluctuation Spectra and Calculating the Bending Moduli 
	
A typical phase contrast image of a red blood cell is shown in figure 4.2. The time 
sequence of contours, obtained from monitoring the cell membrane fluctuations, 
were fitted to the Fourier series [Section 4.2.3] giving a typical fluctuation 
spectrum shown in Figure 4.3. This analysis was repeated for cells treated with 
1mg/ml graphene oxide, as well as cells treated with PBS buffer as a control. 
Figure 4.10 shows an example of the fluctuation spectra observed for cells 
treated with graphene oxide over a time course of ½ h. An overall decrease in 
the mean square fluctuation is observed after treatment with GO, showing the 
greatest affect after the first minute. For all spectra obtained, graphene oxide 
suppresses fluctuations in the lower modes, indicating an increase in bending 
rigidity. GO also has a small effect on the higher modes. From these results it is 
concluded that graphene oxide causes rigidification of the lipid bilayer with 
respect to its bending modulus.  
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Figure 4.10 Contour fluctuation spectra of a red blood cell before treatment (t=0) with 
graphene oxide (black) and treated with 1 mg/ml GO over 1/2 h, showing increasing 
bending rigidity (top to bottom).  
Following the recording of the Fourier fluctuation modes, the results are 
then fitted to the equation 4.6 in order to determine the values for the bending 
modulus, k. Equation 4.6 provides meaningful fits for modes 3 - 18. An example 
fit is given in Figure 4.11. From these fits, values for k were extracted. 
 
 
 
Figure 4.11 A fit of equation 4.6 to a contour fluctuation spectrum for a normal RBC at 0 
min. Modes 3 – 18 are fitted, and values for the bending modulus are extracted. 
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Figure 4.12 shows the average normalised values of k extracted from red blood 
cells treated with graphene oxide over 30 min, with respective errors (n=10). 
Normalisation was achieved using 𝜅 𝜅-, where k0 is the bending modulus at t=0. 
At 0 min, before treatment, the normalised bending modulus is 1.00 ± 0.32. At 30 
min, the normalised bending modulus is 1.76 ± 0.47.  
 
 
Figure 4.12 The normalised data, calculating the bending moduli from the fluctuation 
spectra of 10 red blood cells, treated with graphene oxide over ½ h. (1.75 ± 0.03, n=10) 
There is an approximate two-fold increase of the membrane bending modulus 
observed when red blood cells are treated with graphene oxide. In control 
experiments no change to the bending modulus was observed [Figure 4.13]. The 
average bending modulus for untreated cells was calculated to be 4.59 x 10-19 J, 
which corresponds well to previously recorded values ranging from 1.4 x 10-19 J 
to 4.3 x 10-19 J (141) and from 2 x 10-19 J to 7 x 10-19 J (142). The initial average 
normalised bending modulus is 1.00 ± 0.17, and the final value calculated after 
½ h is 1.02 ± 0.23 (n=10).  
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Figure 4.13 The normalised data, calculating the bending moduli from the fluctuation 
spectra of 10 red blood cells, treated with PBS buffer (1% BSA). (1.01 ± 0.04, n=10). 
Figure 4.12 shows the greatest effect of the graphene oxide occurs within the first 
½ hour. To investigate behaviour at longer times, cells were incubated with 
graphene oxide and were measured at ½ h, 1 h and 2h [Figure 4.14]. The average 
bending moduli were 1.87 ± 0.35, 1.95 ± 0.37 and 1.81 ± 0.28, respectively (n=5).   
 
 
Figure 4.14 The normalised bending modulus calculated for RBCs incubated with 
graphene oxide at room temperature. Fluctuation measurements were taken at 1/2h, 1h 
and 2h. 
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The bending modulus doubled, as in the shorter time experiments, indicating that 
the increase in membrane rigidity occurs immediately after contact of the cells 
with the GO solution and as there is no significant change to the mechanical 
properties after the initial interaction it is likely the graphene oxide does not pass 
through the membrane. There is also no observable toxic effect on the cells as 
the RBCs remain intact, at least as observed by phase contrast imaging.  
The effect of temperature was also investigated. Incubating the red blood 
cells with graphene oxide at 4°C, room temperature and 37°C (body temperature) 
all resulted in an increase in bending modulus. Figure 4.15 shows the average 
values obtained over ½ hour incubation periods (n=5), giving average values of 
1.64 ± 0.33, 1.87 ± 0.35 and 1.69 ± 0.33, respectively.  
 
 
Figure 4.15 The normalised bending modulus of the red blood cell membrane, treated with 
graphene oxide for ½ h, at different temperatures. 
These results show that the interaction of graphene oxide and red blood cells is 
not temperature dependent.  
The effect of the graphene oxide on the mechanical properties of the RBC 
membrane is likely to arise from reorganisation of the lipid bilayer. The Langmuir 
monolayer measurements [Chapter 2] suggested that the GO interacts with the 
outer leaflet of the RBC membrane, with repulsive forces between PS head 
groups of the inner leaflet and GO preventing further incorporation of GO. 
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An increase in bending modulus of the red blood cell membrane also 
occurs in cells exposed to oxidative stress (131) and this may also occur after 
GO exposure since it has been reported to induce oxidative stress in P. 
aeruginosa cells (143) through the production of superoxide radicals and also in 
A549 cells, inducing slight loss of cell viability (59). However, there are significant 
differences between the cell types so GO may interact differently. 
 
	
4.3.2 Absorbance Analysis 
	
Initially, absorbance measurements were carried out using the same method as 
the fluctuation experiments, via buffer exchange of the graphene oxide. However, 
red blood cell membranes tend to stiffen after long exposures to the 420 nm light, 
meaning the light had to be turned off between acquisitions. Without a continuous 
light source cells dropped out of sight, limiting the number of measurements taken 
on cells treated with graphene oxide. To overcome this, the method was altered. 
Measurement of red blood cells, without graphene oxide treatment were first 
taken, changing cell sample for each measurement to avoid long exposures to 
the light. Red blood cells were then added to the graphene oxide suspension 
before being added to the microscope chamber. They were left for ½ h, added to 
the microscope chamber, then the videos were taken over a representative 
number of cells. The absorbance was then calculated at different points across 
the cell to reconstruct the shape profile of the RBC (using ImageJ and MATLAB). 
Figure 4.16 shows the average absorbance intensity (n=5) for normal red blood 
cells and red blood cells treated with graphene oxide. A decrease in the radius is 
observed but little change in absorbance.  
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Figure 4.16 Averaged radial absorption of a red blood cell, before (black) and after 
treatment with 1 mg/ml graphene oxide (red) (14 pixels = 1 µm). 
The RBC profiles suggest GO alters the shape of the red blood cell but does not 
cause any haemoglobin leakage, because the integrated areas of the curve are 
the same. This suggests GO does not penetrate through the whole membrane. 
A decrease in absorbance would be observed if there was a loss of haemoglobin 
from inside the cell. This contradicts some of the literature (60), where loss of 
haemoglobin was reported due to GO damaging the RBC membrane. However, 
this study measured large populations of RBCs. In this thesis, only single cell 
measurements were conducted. 
	 The RBC profiles show a decrease in radius of cells treated with GO. This 
observation is consistent with radial measurements acquired during the 
fluctuation spectroscopy experiments previously discussed. The radius was 
measured for all cells before addition of the graphene oxide, and at selected time 
points after graphene treatment over ½ h. This was repeated for all control cells. 
Figure 4.17 shows the normalised average radius (n=10) as a function of time, 
with a small decrease in radius observed for red blood cells treated with graphene 
oxide.  
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Figure 4.17 Normalised average radius of red blood cells treated with graphene oxide (red) 
and without (black), over 1/2 h. 
A decrease in R1/R0 suggests a loss in membrane surface area, which can 
indicate loss of lipids from the membrane. This provides further evidence that 
graphene interacts with the lipids of the membrane, or alters the structure of the 
membrane.  
From the fluctuation and absorbance analysis, we suggest that graphene 
oxide adsorbs onto the red blood cell membrane but does not enter the cell. There 
are several factors that could drive the adhesion of graphene oxide to the cell 
membrane. Graphene oxide and the cell membrane have similar flexibility which 
could facilitate the two being held together. Theoretical studies have shown the 
bending rigidity of graphene to be similar to the lipid bilayers of cells (144). The 
association of graphene oxide on the membrane could induce interactive forces, 
including electrostatic and hydrophobic interactions, in order to hold the two 
together.  
Graphene oxide has previously been found to interact specifically with 
aquaporin proteins within the cell membrane (145), a protein in high abundance 
in the RBC membrane (146). The authors found GO to enhance membrane 
permeability without penetrating the cell in the breast cancer cell line MCF-7, but 
caused haemolysis in red blood cells (145). Haemolysis has not been observed 
in our work, but it is possible the graphene oxide is interacting with the aquaporin 
proteins. Aquaporin is important in RBCs in determining cell water transport to 
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regulate cell volume. A change in cell volume was not found in our work, so it 
seems unlikely that the activity of this channel is affected. 
	
	
4.3.3 Raman Spectroscopy 
	
To date, there has been no spectroscopic study investigating the interactions of 
GO with RBCs. The main aim of the present work was to use Raman mapping of 
the graphene peaks to investigate the distribution of graphene in or on the cells. 
Obtaining Raman spectra for RBCs proved challenging. One issue was finding a 
cell with GO associated to it, due to a large sample size of cells measured without 
detection of GO (this was not a problem for previous experiments because the 
RBC was found first then treated with GO). Another problem was finding an intact 
RBC. In Figure 4.18 abnormal RBCs can be observed with a serrated membrane. 
These cells are known as echinocytes and can be a result of the ‘glass-effect’ 
which causes morphological changes to RBCs (140). Although, this was not a 
problem with previous experiments, suggesting the RBCs were more sensitive to 
the laser.  
A typical Raman spectrum of graphene oxide is shown in Figure 4.7, with 
its two characteristic peaks (G-peak: 1580 cm-1 and the D-peak: 1350 cm-1). 
Figure 4.8 shows the Raman spectrum of an oxygenated RBC which shows 
characteristic peaks in the same regions as GO. Raman images at selected 
peaks were taken in order to investigate the position of graphene oxide within the 
cell. The peaks chosen to investigate were 1350 cm-1 and 1580 cm-1 (the GO 
peaks) and 2940 cm-1 (the C–H band). Figure 4.18 shows a snapshot of the cell 
analysed in this example. 
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Figure 4.18 A snapshot of the red blood cell chosen for Raman analysis: most of the other 
cell were becoming echinocytic. The sample was incubated with 1 mg/ml graphene oxide 
for 1h at room temperature. 
Figure 4.19 shows the recorded single spectra of RBCs treated with GO at bands 
1350 cm-1, 1580 cm-1 and 2940 cm-1. Spectra a) and b) were taken at 1350 cm-1 
and 1580 cm-1, respectively. The results show clear peaks at both wave numbers, 
characteristic of graphene oxide. However, when compared to the spectra 
obtained for the control RBC [Figure 4.8] peaks were observed in the same 
positions resulting in some ambiguity to which component was producing the 
Raman signal. This limited the information that could be gained from using 
Raman analysis. There appears to be a GO flake in the Raman image scans 
produced in a) and b) shown by a cluster of high intensity [Figure 4.19]. These 
clusters were also observed in all the RBCs successfully analysed (n=4). 
However, the spatial resolution was inadequate to confirm whether the GO is 
inside or outside the cell. In future experiments, depth scans of the sample could 
provide further information on whether the GO is inside the cell, but these would 
take a very long time and the cell might not survive. The Raman image scan 
obtained for control cells [Figure 4.8] shows the 2940 cm-1 C–H band, 
representing C–H vibrations, is concentrated towards the middle of the cell. This 
is possibly from the heating effects of the laser causing the cell to shrink, therefore 
concentrating the C–H material. For future Raman analysis, new imaging 
modalities might be required, for example restricting the imaging to specific 
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peaks, that require less laser power to analyse the cell. This could minimise cell 
damage without losing spectral details. 
 
	
	
	
	
	
	
Figure 4.19 Single Raman spectra obtained using 532 nm excitation wavelength of a red 
blood cell treated with GO. The signal intensities were recorded at the following peaks 
a)1350 cm-1 b)1580 cm-1 and c)2940 cm-1 (left), with the corresponding Raman image scans 
(right).  
a) 
b) 
c) 
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4.4 Conclusions 
	
	
Fluctuation spectroscopy was used to measure and extract values for the bending 
modulus in both red blood cells, and red blood cells treated with graphene oxide. 
The presence of 1 mg/ml graphene oxide suspension increased the bending 
modulus two-fold and is not temperature dependent. The bending modulus was 
calculated at several time points and showed no change. This implies graphene 
oxide adsorption occurs instantaneously. The good reproducibility of the results 
suggests fluctuation spectroscopy can provide a reliable method to quantitatively 
measure the effects of graphene oxide on the red blood cell and on the lipid 
bilayer mechanics. Absorbance analysis shows a decrease in the radius of red 
blood cell, in line with the radial analysis conducted during the fluctuation 
spectroscopy. With no change in absorbance, it is concluded that graphene oxide 
adsorbs to the red blood cell membrane, but does not lead to loss of 
haemoglobin, suggesting that it may not enter the penetrate the membrane. This 
is consistent with the limited information obtained using Raman imaging.
		
 
Chapter 5 Discussions, Conclusions and Further Work 
	
	
This thesis employed a number of techniques to investigate the interaction of 
graphene with cell membranes. From analysing the interactions of graphene 
oxide with Langmuir monolayers of mixed lipid compositions, it was determined 
that the addition of graphene oxide increased the overall surface pressure of the 
monolayers, whilst also decreasing the compressibility. The insertion of GO is 
evident by the increase in trough area observed with GO addition. The nature of 
the interaction depended on the lipid composition of the monolayer. For the inner 
leaflet, initial GO insertion was dependent on pressure, with little GO insertion at 
the condensed pressure phase. The outer leaflet was more permeable to GO, 
suggesting a significant interaction between GO and the negatively charged PS 
head groups present in the inner leaflet mixture.  
 Permeability experiments using bilayer vesicles have shown GO to 
permeate vesicles, without causing full lysis. Using two preparations of vesicles, 
it has been found that permeability can be affected by the composition and 
properties of the vesicles, showing higher permeability with simple vesicles made 
with only one type of lipid. From using simple DOPC vesicles, it can be suggested 
that GO may have a specific interaction with PC head groups. Permeability has 
also been shown to be dependent on GO concentration, with an increase in 
permeability as a result of increasing GO concentration. Steady rates of 
permeation have been found over time, which could suggest GO saturates the 
vesicles, resulting in initial permeation with no further interactions.  
 Further investigation into GO interactions with model cells (RBCs) showed 
GO to be non-toxic resulting in no haemolysis of the cells, and in contrast to the 
vesicles we found no evidence of membrane penetration. Fluctuation 
spectroscopy analysis found GO to increase the bending modulus of RBC cell 
membranes, meaning the membrane became more rigid, probably because of 
the interactions observed in the Langmuir trough. Radial and absorbance 
analysis showed the adsorption of GO decreased the radius of the cell, 
suggesting possible loss in membrane surface area. The absorbance results also 
showed no loss of haemoglobin from the cells, suggesting GO does not 
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completely permeate the membrane, consistent with the results of Raman 
imaging.   
 GO has shown promise as a good biocompatible nanomaterial. The 
present results suggest that when GO interacts with biological cells it will interact 
with the outer leaflet of the membrane, but not the inner. Vesicle analysis also 
showed good permeability using vesicles composed of lipids found in the outer 
leaflet. No haemolysis was shown with RBCs indicating the membrane is not fully 
permeated, suggesting possible interactions with the outer leaflet of the 
membrane but not the inner. This provides further evidence of strong repulsive 
forces between GO and PS head groups. There is a decrease in the radius 
suggesting there could be loss of membrane area from the outer leaflet. GO has 
been shown to extract phospholipids from the membranes of E.coli (147). 
However, in this work lipid extraction from both inner and outer leaflet has been 
reported, resulting in complete loss of membrane integrity. The ‘self-healing’ 
property used to describe the action of permeated DOPC vesicles (117) could be 
considered as a possible mechanism for GO interactions with RBCs. It is possible 
the GO extracts lipids from the outer leaflet which then ‘re-seals’ resulting in an 
increase in the bending modulus of the membrane.  
 Further investigation is required to determine how the GO interacts with 
the membrane, and whether, as we hypothesise, PS is the specific component 
of the lipid mixtures used in the present study which interacts with GO.  
 
 
5.1 Future Work 
	
 
5.1.1 Complementary Techniques for Langmuir Monolayer Studies 
	
There are several techniques that can be used to further investigate the effects 
of the graphene oxide on the inner and outer membrane leaflet. Fluorescence 
microscopy using fluorescently labelled lipids provides a strong contrast between 
domains (148). Fluorescently labelled lipids can be incorporated into the lipid 
mixtures to allow visualisation of lipid domains and their spatial distribution within 
the monolayer. This technique could be used to determine whether any changes 
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in domain properties are observed after addition of GO. The domain structure of 
cell membranes is believed to be very important to their function so establishing 
whether this is disrupted by GO will be important in further assessing its biological 
properties.  
Brewster angle microscopy (BAM) can also be used to detect domain 
structure, as well as observing phase changes and phase separation. It is a dark 
field microscopy technique (149) utilising polarised light to observe changes in 
the refractive index of the water subphase in the presence of lipid molecules 
which provides a contrast between lipid domains. An advantage of using this 
technique is that no addition of fluorescent lipids or probes to the monolayer is 
required, therefore giving a true representation of the lipid monolayer being 
studied. Further development of BAM has also lead to the accurate measurement 
of the tilt angles in lipid phases (150).  
 The Langmuir-Blodgett technique can also be used to deposit lipid 
monolayers with GO incorporated onto solid substrates to further probe the 
monolayer. Using techniques such as AFM can provide information of the 
morphology of the deposited film and can confirm whether GO has been 
incorporated into the monolayer. Due to the width of GO flakes, it has been 
proposed the GO will interact “edge-on”. Langmuir-Blodgett deposition could be 
used to confirm the orientation of the GO, and to help understand the mechanism 
in which GO inserts into the membrane.   
 
 
5.1.2 Graphene Oxide Interaction with Phosphatidylserine 
	
Several techniques used in this thesis can be applied to investigate GO 
interactions with PS head groups. A series of experiments investigating different 
compositions of bilayer vesicles can provide further evidence of GO permeability. 
Forming pure DOPS GUVs, as well as mixed vesicles containing PS lipids, will 
determine GO permeability, consequently giving information on its permeability 
towards the inner leaflet of the membrane. Fluctuation spectroscopy can also be 
used to determine whether GO affects the bilayer mechanics of the vesicles. 
Using this technique on a range of vesicles with different lipid compositions could 
distinguish specific interactions of GO with a specific lipid. Further Langmuir 
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monolayer analysis can also be used on one lipid systems to investigate the 
individual components of the inner/outer membrane leaflet.  
	
	
5.1.3 Graphene Oxide Interaction with Proteins 
	
Little is known about how GO may interact with the proteins of the cell membrane. 
It is possible to form vesicle and monolayer systems with integral trans-
membrane proteins and/or membrane associated proteins, which would allow 
further characterisation of the physical effects of graphene oxide on the cell 
membrane using the techniques previously described in Chapters 2 and 3. The 
addition of proteins systematically to lipid systems can be used as a tool to 
investigate any specific interactions that may occur between GO.  
One point for discussion was a previous study reporting GO to interact 
specifically with aquaporin proteins (a water channel protein) within cell 
membranes (145). To investigate this, vesicles can be constructed incorporating 
the protein into the bilayer to determine whether this increases membrane 
permeability, or in fact causes haemolysis according to the previous results. 
Interactions with the proteins of the RBC cytoskeleton are also of great interest 
to further research the interactions of GO with RBCs.  
 
 
5.1.4 Complementary Techniques for Red Blood Cell Measurements 
	
One of the questions unanswered in this thesis is the extent to which GO 
interaction disrupts the organisation of membrane lipids, in addition to its potential 
effect on domain structure as discussed above. There are a number of techniques 
which could be employed for this, which include: measuring the membrane dipole 
potential using ratiometric fluorescence imaging, and measuring the membrane 
surface electrostatic potential using a specific fluorescent probe that is sensitive 
to changes in charge density (151). These techniques could test our hypothesis 
of charge interactions between GO and PS head groups. 
  To assess the possibility GO may cause oxidative stress to RBCs, which 
has previously been associated with an increase in the bending modulus of RBC 
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membranes (131), the generation of reactive oxygen species (ROS) could be 
measured at the single cell level using oxidant-sensitive dyes (143) (59).  
 
 
5.1.5 Interactions of Graphene Oxide with Endothelial and Epithelial Cells 
	
To extend this research to other biological cells, to further investigate its 
biocompatibility, it would be interesting to study how graphene oxide interacts 
with cells with a more complex structure. An obvious starting point would be to 
look at endothelial and epithelial cells, a first point of contact for GO entering the 
body. Endothelial cells line the interior surface of blood vessels, forming an 
interface between circulating blood or lymph in the lumen and the rest of the 
vessel wall. Epithelial cells would be the first barrier for GO entering the lungs or 
digestive system.   
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